WO2004004676A1 - Vesicle dispersion and cosmetic containing the same - Google Patents

Vesicle dispersion and cosmetic containing the same Download PDF

Info

Publication number
WO2004004676A1
WO2004004676A1 PCT/JP2003/008517 JP0308517W WO2004004676A1 WO 2004004676 A1 WO2004004676 A1 WO 2004004676A1 JP 0308517 W JP0308517 W JP 0308517W WO 2004004676 A1 WO2004004676 A1 WO 2004004676A1
Authority
WO
WIPO (PCT)
Prior art keywords
component
vesicle
vesicle dispersion
dispersion according
mass
Prior art date
Application number
PCT/JP2003/008517
Other languages
French (fr)
Japanese (ja)
Inventor
Yukako Fujiwara
Original Assignee
Kose Corporation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kose Corporation filed Critical Kose Corporation
Priority to KR1020057000160A priority Critical patent/KR101052493B1/en
Priority to JP2004519263A priority patent/JP4527530B2/en
Priority to AU2003246269A priority patent/AU2003246269A1/en
Priority to CA002491725A priority patent/CA2491725A1/en
Priority to US10/518,549 priority patent/US20050287095A1/en
Publication of WO2004004676A1 publication Critical patent/WO2004004676A1/en
Priority to HK06100016.4A priority patent/HK1079982B/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/11Encapsulated compositions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14Liposomes; Vesicles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/68Sphingolipids, e.g. ceramides, cerebrosides, gangliosides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/40Chemical, physico-chemical or functional or structural properties of particular ingredients
    • A61K2800/52Stabilizers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02Preparations containing skin colorants, e.g. pigments
    • A61Q1/04Preparations containing skin colorants, e.g. pigments for lips
    • A61Q1/06Lipsticks
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02Preparations containing skin colorants, e.g. pigments
    • A61Q1/10Preparations containing skin colorants, e.g. pigments for eyes, e.g. eyeliner, mascara

Definitions

  • the present invention relates to a vesicle dispersion containing a component having an excellent moisturizing effect stably, a method for producing the vesicle dispersion, and a cosmetic containing the vesicle dispersion.
  • a combination of a nonionic surfactant and an ionic surfactant is used, and a method for finely and stably blending lipids (Japanese Patent Application Laid-Open No. 1991-1988) No. 14), a method of forming a liquid crystal of a lipid, a surfactant, and an oil agent (Japanese Patent Application Laid-Open No. 6-34563), a method of precipitating a lipid and a surfactant from an organic solvent, and A method using a complex of the above (Japanese Patent Application Laid-Open No. 11-199462) or a method using a ribosome (vesicle composed of a phospholipid bilayer membrane) has been studied.
  • sphingosine such as ceramide generally has poor solubility in oils
  • even the above method requires a relatively large amount of surfactants and solvents, and thus has a problem in safety as a cosmetic.
  • a technique was required to completely remove the large amount of organic solvents used to obtain the complex consisting of lipids and surfactants.
  • phospholipids are generally unstable substances, and it has been difficult to ensure long-term storage stability as cosmetics.
  • the present inventors have conducted intensive studies on a means for stably blending sphingosine such as ceramide or a derivative thereof.
  • sucrose fatty acid ester, sphingosine and an aqueous component were used as constituents to form an organic solvent. It was found that a very stable vesicle structure could be formed without using any chemicals.
  • sphingosine or a derivative thereof can be stably compounded in cosmetics and the like, and it is possible to provide cosmetics and the like having no stickiness and excellent in moisturizing feeling, and completed the present invention.
  • the present invention provides at least the following components (A), (B) and (C)
  • a vesicle dispersion comprising:
  • the present invention provides a cosmetic containing the vesicle dispersion.
  • the vesicle dispersion means a vesicle composed of a lipid multilayer film dispersed in an aqueous component.
  • sucrose fatty acid ester (component (A)) constituting the vesicle dispersion of the present invention any one can be used as long as it is generally used for cosmetics.
  • Sucrose has eight hydroxyl groups in one molecule, and these hydroxyl groups are ester-bonded to fatty acids to form sucrose fatty acid esters.
  • the number of substitutions of the hydroxyl groups by the fatty acids (esterification degree) is as follows. Things can also be used. However, monoesters, diesters or triesters are preferred, with monoesters being particularly preferred.
  • a mixture of sucrose fatty acid esters having different degrees of esterification may be used, It is preferable that 50% by mass (hereinafter simply referred to as “%”) of the component (A) be at least a sucrose fatty acid monoester.
  • part or all of the component (A) is a hydrophilic sucrose fatty acid ester.
  • 1 "and 8 of the component (A) are preferably 7 to 18 and particularly preferably 12 to 16.
  • the fatty acid to be subjected to the ester reaction is preferably a saturated or unsaturated, straight or branched chain having 8 to 24 carbon atoms, and particularly preferably a fatty acid having 14 to 20 carbon atoms.
  • fatty acids are unsaturated fatty acids such as oleic acid and linolenic acid, since these act as antioxidants on the skin and help prevent aging.
  • fatty acid constituting the component (A) include palmitic acid, stearic acid, isostearic acid, oleic acid, and linolenic acid.
  • preferred component (A) include, for example, sucrose monostearate, sucrose monoisostearate, sucrose diisostearate, sucrose monopalmitate, sucrose dipalmitate, sucrose monopalletate. Sucrose monolinoleate, sucrose dilinoleate, sucrose trilinoleate and the like.
  • the sphingosine and / or its derivative (component (B); hereinafter, referred to as “sphingosines”) constituting the vesicle dispersion of the present invention may be any substance having a sufingosine skeleton. Examples thereof include sphingosine, ceramide, sphingomyelin, cerebroside and the like, and one or more of these can be used.
  • ceramide generally has a high melting point, so that it is usually difficult to stably blend it into cosmetics. However, according to the present invention, this is possible, or It is particularly preferable to use ceramide as the component (B) from the viewpoint of increasing the water holding power and enhancing the moisturizing effect of the cosmetic preparation.
  • Ceramides used in cosmetics include ceramides produced by using yeast, ceramides produced by chemical synthesis, and ceramides obtained from plants. All of them are suitably used. Specific examples include ceramides 1 to 6, among which ceramide 2, ceramide 3 and ceramide 6 are particularly preferred.
  • the aqueous component (component (C)) constituting the vesicle dispersion of the present invention may be any water or water-soluble component.
  • water monohydric compounds such as ethyl alcohol and isopropyl alcohol; Alcohols; Dalicols such as propylene glycol, 1,3-butylene glycol, dipropylene glycol, and polyethylene glycol; Glycerols such as glycerin, diglycerin, and polyglycerin; Aloe vera, Hamamelis, Cucumber, lemon, lavender, and rose And one or more of these can be used, but water or a mixture with water is preferred.
  • the vesicle dispersion of the present invention may further comprise, as optional components, fatty acids having a melting point of 80 ° C or less and / or higher alcohols having a melting point of 80 ° C or less.
  • (D) component fatty acids having a melting point of 80 ° C or less and / or higher alcohols having a melting point of 80 ° C or less.
  • the incorporation of the component (D) increases the compatibility of sphingocins, suppresses crystal precipitation, and can further improve the stability of the vesicle.
  • any fatty acid or higher alcohol having a melting point of 80 ° C. or less may be saturated or unsaturated, branched or linear, but has a branch. It is preferable that one or two or more thereof can be used.
  • the vesicle dispersion of the present invention may contain sterols (component (E)) as its constituent components.
  • component (E) any substance having a sterol skeleton or a derivative thereof can be used.
  • the vesicle dispersion of the present invention has as its constituents a medicinal agent (F) selected from the group consisting of whitening agents, anti-inflammatory agents, vitamins, amino acids, humectants and antioxidants. ) Can be contained.
  • F medicinal agent
  • This component (F) is a fat-soluble or water-soluble active ingredient, and specifically includes whitening agents such as ascorbic acid and its derivatives, licorice extract; glycyrrhetinic acid and its derivatives, glycyrrhizic acid and its derivatives, Anti-inflammatory agents such as azulene; retinol, vitamin A derivatives, pyridoxine hydrochloride and its derivatives, nicotinic acid derivatives, vitamins such as vitamin E and its derivatives; amino acids such as histidine, arginine, serine; collagen, hyaluronic acid, PCA, etc.
  • whitening agents such as ascorbic acid and its derivatives, licorice extract; glycyrrhetinic acid and its derivatives, glycyrrhizic acid and its derivatives, Anti-inflammatory agents such as azulene; retinol, vitamin A derivatives, pyridoxine hydrochloride and its derivatives, nic
  • Preferred examples include a humectant; an antioxidant such as butylhydroxytoluene, and the like or two or more of these can be used.
  • the preferred content ranges of the respective components with respect to the entire vesicle dispersion of the present invention are as follows. Component Preferred range
  • (F) component 0 5% 0.01 to 2%
  • the total amount of the components (A) and (B) is preferably 0.1 to 25% based on the whole vesicle dispersion.
  • composition ratio of the component (A) and the component (B) is not particularly limited, but the content of the component (B) is preferably (A) in view of the moisturizing effect or the stability of the vesicle dispersion. It is preferable that the content ratio of the component is 0.001 to 0.4 times by mass. Especially preferably, it is 0.01 times to 0.2 times.
  • the content of the component (E) is not particularly limited, but is preferably 0.001 to 0.4 times, more preferably 0.1 to 0.2, by mass of the content of the component (A). It is particularly preferred that it be twice. Within this range, the stability of the vesicle dispersion and the moisturizing effect on the skin can be further improved.
  • Various methods can be used as a method for producing the vesicle dispersion of the present invention using each of the above-mentioned components. One of the methods is as follows. That is, at least the components (A) and (B), and if necessary, the components (D) and (E) are dissolved or dispersed in the component (C) at a temperature of 40 ° C or higher.
  • the method is preferred.
  • the method for producing the vesicle dispersion includes a method in which components constituting the vesicle are sufficiently swollen in water at a temperature equal to or higher than the Tc temperature (gel-liquid crystal transition temperature), followed by stirring and stirring (Patent 31).
  • Tc temperature gel-liquid crystal transition temperature
  • Patent 31 No. 261 93
  • a method of forming a thin film of a phospholipid using an organic solvent, and then adding water or an aqueous solution to obtain minute ribosomes by, for example, ultrasonic irradiation, is conventionally known.
  • the vesicle dispersion of the present invention uses a polyhydric alcohol such as dipropylene glycol or glycerin as the component (C) without using an organic solvent, and dissolves each vesicle component in this.
  • a polyhydric alcohol such as dipropylene glycol or glycerin
  • a vesicle dispersion can be easily prepared. Easy vesicle dispersion of less than mm It is possible to obtain.
  • the component (C) used in the above-mentioned dissolution / dispersion liquid preparation is as described above. Particularly, dipropylene glycol is particularly preferred.
  • the component (C) on the side to which the dissolution / dispersion solution is added preferably contains water at 20% or more, and particularly preferably contains water as a main component.
  • the use of the component (D) at the same time as the preparation of the above-mentioned dissolution / dispersion liquid lowers the melting point of the component (B), suppresses crystal precipitation due to compatibility with the component (B), and reduces the vesicle dispersion. It is particularly preferred in that it improves the stability of the device.
  • the vesicle dispersion of the present invention thus obtained can be used in combination with other cosmetic ingredients to obtain a cosmetic.
  • the form of the cosmetic is not particularly limited, and it can be in any form such as a solution type, a solubilizing type, an emulsifying type, an oil type, an aqueous type, or a combination of these types, such as a two-layer type or a three-layer type.
  • the cosmetic of the present invention may be a skin care cosmetic, a hair cosmetic, a makeup cosmetic, or the like, but is preferably a skin care cosmetic. Above all, in order to exhibit a moisturizing effect, it is preferable to use an aqueous dosage form such as a lotion, an emulsion or a cream.
  • the blending amount of the vesicle dispersion of the present invention with respect to the whole cosmetic can be selected according to each dosage form, but is preferably 0.1 to 100%.
  • the cosmetic of the present invention includes, in addition to the vesicle dispersion of the present invention, components used in ordinary cosmetics, such as water, water-soluble components, humectants, oils, surfactants, and thickeners.
  • components used in ordinary cosmetics such as water, water-soluble components, humectants, oils, surfactants, and thickeners.
  • Agents, powders, pigments, ultraviolet absorbers, film-forming agents, pH adjusters, anti-fading agents, antioxidants, defoamers, cosmetic ingredients, preservatives, fragrances, and the like can be further appropriately compounded.
  • water-soluble components examples include the monoalcohols, glycols, glycerols, plant extracts, etc. listed in the component (C), and sorbies, such as sugar, maltitol, and sucrose, sodium chloride, and chloride. Electrolytes such as magnesium and sodium lactate can also be used.
  • humectant examples include protein, mucopolysaccharide, collagen, and elastin.
  • Oils include hydrocarbons, oils and fats, waxes, hardened oils, regardless of their origin, such as animal oils, vegetable oils, and synthetic oils, and solid oils, semisolid oils, liquid oils, and volatile oils. Ester oils, fatty acids, higher alcohols, silicone oils, fluorinated oils, lanolin derivatives, oily gelling agents, etc. are used.
  • any surfactant generally used in cosmetics can be used.
  • thickeners examples include guar gum, sodium chondroitin sulfate, sodium hyaluronate, gum arabic, sodium alginate, carrageenan, methylcellulose, hydroxyethyl cellulose, carboxymethylcellulose, lipoxyvinyl polymer, polyvinyl alcohol, polyvinylpyrrolidone, and polyacrylyl. And water-soluble polymers such as acid sodium.
  • the powder is not particularly limited by a plate-like, spindle-like, needle-like or spherical shape, or a particle diameter, a particle structure such as porous or non-porous, and the like.
  • Body laminated film powder, organic powder, pigment powder, composite powder and the like.
  • These powders may be subjected to a surface treatment by a known method using a fluorine compound, a silicone oil agent, metal soap, a wax, a surfactant, a fat, a hydrocarbon, or the like.
  • UV absorber examples include benzophenone-based, PABA-based, caesmic-acid-based, salicylic-acid-based, 4-tert-butyl-4'-methoxydibenzoylmethane, and xyxbenzone.
  • Emulsion polymer form such as (meth) alkyl acrylate copolymer, etc.
  • PH regulators include ⁇ -hydroxy acids such as lactic acid and citric acid and salts thereof, edetates, and antioxidants For example, Q!
  • the vesicle dispersion of the present invention obtained as described above has an average particle size of 70 to 200 OO Atm, and is concentric.
  • a vesicle which is a sphere having a multilayered structure (so-called onion-like structure), is suspended in an aqueous medium, and has excellent skin moisturizing effect. Sphingosines such as ceramide are stably contained in the vesicle. Possible It is.
  • Example 1 Example 1
  • ceramide and 0.1 g of isostearic acid were weighed and mixed by heating at 90 ° C. Then, 4 g of dipropylene glycol in which 0.5 g of sucrose fatty acid ester * 2 was dispersed was added to the mixture, and 70 ° C was added. This was added to 10 g of purified water at 70 ° C, stirred and dispersed, and then cooled to obtain a vesicle dispersion (the component (B) was 0.2 times the component (A)). Obtained.
  • Ceramide (0.01 g) and isostearic acid (0.1 g) were weighed and mixed by heating at 90 ° C. Then, to this mixture was added 0.5 g of sucrose fatty acid ester ' 2 dispersed in dipropylene glycol (4 g). This was added to 10 g of purified water at 70 ° C, stirred and dispersed, and then cooled to obtain a vesicle dispersion (the component (B) was 0.02 times the component (A)). Obtained.
  • Ceramide (0.2 g) and isostearic acid (0.1 g) were weighed and mixed by heating at 90 ° C. Then, to this mixture, 0.5 g of sucrose fatty acid ester was dispersed in 4 g of dipropylendalicol, and the mixture was added at 70 ° C. Mix evenly. This was added to 10 g of purified water at 70 ° C., stirred and dispersed, and then cooled to obtain a vesicle dispersion (the component (B) was 0.4 times the component (A)).
  • ceramide 0.005 g of ceramide, 0.005 g of phytosterol and 0.1 g of isostearic acid were weighed and mixed by heating with 9 (TC. Then, 4 g of dipropylene glycol in which 0.5 g of sucrose fatty acid ester was dispersed was added to this mixture. In addition, the mixture was uniformly mixed at 70 ° C. This was added to 10 g of purified water at 70 ° C., stirred and dispersed, and then cooled, whereby the vesicle dispersion ((B) component (A) (0.01 times the component).
  • Vesicle lotions (products 1 to 3 of the present invention) were prepared by the composition shown in Table 2 and the following production method.
  • Emulsion lotion is a liquid crystal
  • Example 5 The dispersion stability, moisturizing effect, non-stickiness and smell of the vesicle lotion obtained in Example 5 (Products 1 to 3 of the present invention), the liposome lotion of Comparative Example 2 and the emulsified lotion of Comparative Example 3 The change was evaluated by the following method. The results are shown in Table 3.
  • Each lotion was left in a 40 ° C constant temperature bath for one month, then returned to room temperature, and the change in odor at the bottle mouth was compared with that of the room-temperature storage product, and judged according to the following criteria.
  • vesicle lotions of Example 5 were excellent in moisturizing effect and usability, good in dispersion stability, and the change in odor was within an acceptable range.
  • vesicle dispersions (2) to (4) were used instead of vesicle dispersion (1) used in Example 5, All of the cosmetics obtained were favorable in all respects of dispersion stability, moisturizing effect, non-stickiness, and change in odor.
  • a cream was prepared according to the following composition and manufacturing method, and its dispersion stability and moisturizing effect were evaluated.
  • A Components 1 to 5 and 15 were heated and mixed at 70 ° C.
  • B Components 6 to 14 were heated and mixed at 70 ° C.
  • Example 7 The cream of Example 6 was excellent in moisturizing feeling and good in stability when any of the vesicle dispersions (1) to (4) was used.
  • Example 7
  • An emulsion was prepared according to the following composition and production method, and its dispersion stability and moisturizing effect were evaluated.
  • Example vesicle dispersion "15.0
  • a components 1 to 7 were heated and mixed at 70 ° C.
  • the B components 8 to 13 were heated and mixed at 70 ° C.
  • Example 8 When the emulsion of Example 7 used any of the vesicle dispersions (1) to (4), the emulsion had excellent moisturizing feeling and good stability.
  • Example 8 When the emulsion of Example 7 used any of the vesicle dispersions (1) to (4), the emulsion had excellent moisturizing feeling and good stability.
  • a stick-shaped eye cream was prepared according to the following composition and production method, and evaluated for dispersion stability and moisturizing effect.
  • A: 1 to 7 were uniformly dissolved at 100 ° C.
  • B was poured into a stick container, cooled and solidified to obtain a stick-shaped eye cream.
  • Example 9 The stick-shaped eye cream of Example 8 was excellent in moisturizing sensation and good in stability when any of the vesicle dispersions (1) to (4) was used.
  • Example 9 The stick-shaped eye cream of Example 8 was excellent in moisturizing sensation and good in stability when any of the vesicle dispersions (1) to (4) was used.
  • Sticky lipstick A stick-like lipstick was prepared and evaluated according to the following composition and manufacturing method. (Component) (%)
  • Example vesicle dispersion ' 6 0.5
  • Vesicle dispersion A vesicle dispersion prepared in the same manner as the vesicle dispersion (1), except that the purified water of each of (1) to (4) was changed to 5 g.
  • A Components 1 to 8 were uniformly heated and dissolved.
  • B Components 9 to 16 were uniformly mixed with A.
  • B was melt-filled into a mold and cooled to obtain a stick-like lipstick.
  • Example 10 Each of the stick-like lipsticks of Example 9 was excellent in terms of non-stickiness, moisturizing feeling and tactiness, and particularly had a smooth skin contact.
  • Example 10
  • a serum was prepared by the following composition and production method, and the dispersion stability and the moisturizing effect were evaluated and determined.
  • Vesicle dispersions Prepared in the same way as vesicle dispersions (1) to (4), except that sphingomyelin was used instead of ceramides 1 to 4 and dipropylene glycol was reduced to half the volume. Vesicles.
  • sucrose fatty acid ester was dispersed in 4 g of dipropylene glycol and 0.1 g of sucrose linolenate.
  • Add 0.05 g of vitamin E and homogenously mix at 70 ° C add this solution to 10 g of purified water at 70 ° C in which 0.1 g of histidine is dissolved, stir and disperse, then cool. Obtained by
  • the serum of Example 10 was excellent in moisturizing feeling and good in stability even when any of the four kinds of vesicle dispersion # 8 and vesicle dispersion was used in combination. Availability
  • a vesicle dispersion in which sphingosines such as ceramide are stably contained can be easily obtained.
  • This vesicle dispersion can be incorporated into cosmetics and the like, and the cosmetics containing the vesicle dispersion are excellent in dispersion stability, moisturizing effect, non-stickiness, anti-odor and the like.

Abstract

A vesicle dispersion comprised of at least a sucrose fatty acid ester (A), sphingosine and/or a derivative thereof (B) and a water base component (C); and a cosmetic comprising the vesicle dispersion. This vesicle dispersion enables stably containing sphingosines such as ceramides which are exellent in the moisture retention effect for skin. The cosmetic obtained by mixing the vesicle dispersion thereinto is excellent in moisture retention effect, storage stability, etc.

Description

明細書 べシクル分散物およびこれを含有する化粧料 技術分野  Technical Field Vesicle dispersion and cosmetics containing the same
本発明は保湿効果に優れた成分を安定に含有したべシクル分散物とその製造 方法および該べシクル分散物を含有する化粧料に関する。 背景技術  TECHNICAL FIELD The present invention relates to a vesicle dispersion containing a component having an excellent moisturizing effect stably, a method for producing the vesicle dispersion, and a cosmetic containing the vesicle dispersion. Background art
セラミド等の角質細胞間脂質が、 角質層のバリヤ一機能に深く関わっている ことが明らかにされて以来、 これを配合した保湿製剤の開発が試みられてきた。 しかし、 セラミドは結晶性が高く、 安定性の観点から化粧料への配合量には自 ずと制約があり、 多量に配合できなかった。 従って、 セラミドの有する水分保 持機能をより効果的に発現するために、 セラミドを多量に配合しても安定で、 結晶析出等の問題を生じることのない化粧料の開発が望まれていた。  Since it was revealed that keramide and other intercellular lipids are deeply involved in the barrier function of the stratum corneum, attempts have been made to develop moisturizers containing this. However, ceramide has high crystallinity, and the amount of ceramide in cosmetics is naturally limited from the viewpoint of stability. Therefore, in order to more effectively express the water retention function of ceramide, it has been desired to develop a cosmetic that is stable even when a large amount of ceramide is blended and does not cause problems such as crystal precipitation.
上記目的達成のために、 例えば、 非イオン性界面活性剤とイオン性界面活性 剤を組み合わせて用いることにょリ、 脂質を微細かつ安定に配合できるように する方法 (特開平 4一 1 9 3 8 1 4号公報) 、 脂質と界面活性剤と油剤との液 晶にする方法 (特開平 6— 3 4 5 6 3 3号公報) 、 脂質と界面活性剤を有機溶 媒から析出せしめて、 それらの複合体を利用する方法 (特開平 1 1 — 1 9 9 4 6 2号公報) 、 あるいはリボソーム (リン脂質二分子膜からなるべシクル) を 用いる方法等が検討されてきた。  In order to achieve the above object, for example, a combination of a nonionic surfactant and an ionic surfactant is used, and a method for finely and stably blending lipids (Japanese Patent Application Laid-Open No. 1991-1988) No. 14), a method of forming a liquid crystal of a lipid, a surfactant, and an oil agent (Japanese Patent Application Laid-Open No. 6-34563), a method of precipitating a lipid and a surfactant from an organic solvent, and A method using a complex of the above (Japanese Patent Application Laid-Open No. 11-199462) or a method using a ribosome (vesicle composed of a phospholipid bilayer membrane) has been studied.
しかしながら、 セラミド等のスフインゴシンは、 一般に油剤への溶解性が悪 いため、 上記方法であっても比較的多量の界面活性剤や溶媒類が必要であり、 化粧料としての安全性に問題があった。 また、 有機溶媒の混入が嫌われる化粧 料に配合する場合は、 脂質と界面活性剤からなる複合体を得るために使用した 大量の有機溶剤を完全に除去する技術が必要であった。 さらに、 リン脂質は一 般的に不安定な物質であリ、 化粧料として長期保存安定性を確保することが難 しかった。  However, since sphingosine such as ceramide generally has poor solubility in oils, even the above method requires a relatively large amount of surfactants and solvents, and thus has a problem in safety as a cosmetic. . In addition, in the case of blending into cosmetics where the incorporation of organic solvents is disliked, a technique was required to completely remove the large amount of organic solvents used to obtain the complex consisting of lipids and surfactants. Furthermore, phospholipids are generally unstable substances, and it has been difficult to ensure long-term storage stability as cosmetics.
従って、 セラミド等のスフインゴシンを含有する系を長期にわたって安定化 させることにより、 保湿効果、 保存安定性等に優れた化粧料等の開発が望まれ ていた。 発明の開示 Therefore, systems containing sphingosine such as ceramide can be stabilized for a long time. By doing so, the development of cosmetics and the like having excellent moisturizing effects and storage stability has been desired. Disclosure of the invention
かかる実状において、 本発明者らはセラミド等のスフインゴシンまたはその 誘導体を安定に配合する手段について鋭意検討を進めた結果、 ショ糖脂肪酸ェ ステル、 スフインゴシンおよび水性成分を構成成分とすることにより、 有機溶 剤などを使用しなくても、 極めて安定なべシクル構造を形成することを見いだ した。 その結果、 スフインゴシンまたはその誘導体を安定的に化粧料等に配合 できるようになり、 ベたつきがなく、 保湿感に優れる化粧料等を提供できるこ とを見出し本発明を完成した。  Under such circumstances, the present inventors have conducted intensive studies on a means for stably blending sphingosine such as ceramide or a derivative thereof. As a result, the sucrose fatty acid ester, sphingosine and an aqueous component were used as constituents to form an organic solvent. It was found that a very stable vesicle structure could be formed without using any chemicals. As a result, it has been found that sphingosine or a derivative thereof can be stably compounded in cosmetics and the like, and it is possible to provide cosmetics and the like having no stickiness and excellent in moisturizing feeling, and completed the present invention.
すなわち本発明は、 少なくとも次の (A ) 成分、 (B ) 成分および (C ) 成 分  That is, the present invention provides at least the following components (A), (B) and (C)
(A) ショ糖脂肪酸エステル  (A) Sucrose fatty acid ester
( B ) スフインゴシンおよび/またはその誘導体  (B) Sphingocin and / or a derivative thereof
( C) 水性成分  (C) Aqueous component
を構成成分とするべシクル分散物を提供するものである。 And a vesicle dispersion comprising:
また本発明は、 前記べシクル分散物を含有する化粧料を提供するものである。 発明を実施するための最良の形態  Further, the present invention provides a cosmetic containing the vesicle dispersion. BEST MODE FOR CARRYING OUT THE INVENTION
本明細書中においてべシクル分散物とは、 脂質の多層膜からなる小胞体が水 性成分中に分散したものを意味する。  In the present specification, the vesicle dispersion means a vesicle composed of a lipid multilayer film dispersed in an aqueous component.
本発明のべシクル分散物を構成するショ糖脂肪酸エステル ( (A) 成分) は、 通常、 化粧料に使用されるものであればいずれのものも使用できる。 ショ糖は 1分子中に 8個の水酸基を持っており、 この水酸基が脂肪酸とエステル結合し てショ糖脂肪酸エステルを形成するが、 この脂肪酸による水酸基の置換数 (ェ ステル化度) はいずれのものも使用できる。 しかし、 モノエステル、 ジエステ ルまたは卜リエステルが好ましく、 特に好ましくはモノエステルである。 それ らエステル化度の異なるショ糖脂肪酸エステルの混合物であってもよいが、 ( A ) 成分の 5 0質量% (以下、 単に 「%」 と記載する) 以上がショ糖脂肪酸 モノエステルであることが好まし tゝ。 As the sucrose fatty acid ester (component (A)) constituting the vesicle dispersion of the present invention, any one can be used as long as it is generally used for cosmetics. Sucrose has eight hydroxyl groups in one molecule, and these hydroxyl groups are ester-bonded to fatty acids to form sucrose fatty acid esters. The number of substitutions of the hydroxyl groups by the fatty acids (esterification degree) is as follows. Things can also be used. However, monoesters, diesters or triesters are preferred, with monoesters being particularly preferred. A mixture of sucrose fatty acid esters having different degrees of esterification may be used, It is preferable that 50% by mass (hereinafter simply referred to as “%”) of the component (A) be at least a sucrose fatty acid monoester.
長期にわたる安定性を確保するために、 (A ) 成分の一部または全てが親水 性のショ糖脂肪酸エステルであることが好ましい。 具体的には、 (A ) 成分の 1"1し 8が7〜1 8であることが好ましく、 1 2〜1 6であることが特に好まし い。  In order to secure long-term stability, it is preferable that part or all of the component (A) is a hydrophilic sucrose fatty acid ester. Specifically, 1 "and 8 of the component (A) are preferably 7 to 18 and particularly preferably 12 to 16.
また、 エステル反応する脂肪酸は、 炭素数が 8〜 2 4の飽和または不飽和の、 直鎖あるいは分岐を持つものが好ましく、 特に脂肪酸の炭素数が、 1 4 ~ 2 0 であるものが好ましい。  Further, the fatty acid to be subjected to the ester reaction is preferably a saturated or unsaturated, straight or branched chain having 8 to 24 carbon atoms, and particularly preferably a fatty acid having 14 to 20 carbon atoms.
さらに、 かかる脂肪酸の少なくとも一部が、 ォレイン酸やリノレン酸等のよ うな不飽和脂肪酸であることが、 これらが皮膚上で抗酸化剤としてはたらき、 老化防止に役立つという点でよリ好ましい。  Further, it is more preferable that at least a part of such fatty acids are unsaturated fatty acids such as oleic acid and linolenic acid, since these act as antioxidants on the skin and help prevent aging.
従って、 (A ) 成分を構成する脂肪酸の好ましい具体例としては、 パルミチ ン酸、 ステアリン酸、 イソステアリン酸、 才レイン酸、 リノレン酸が挙げられ る。  Therefore, preferred specific examples of the fatty acid constituting the component (A) include palmitic acid, stearic acid, isostearic acid, oleic acid, and linolenic acid.
また、 好ましい (A ) 成分の具体例としては、 例えば、 ショ糖モノステアレ 一卜、 ショ糖モノイソステアレー卜、 ショ糖ジイソステアレー卜、 ショ糖モノ パルミテート、 ショ糖ジパルミテート、 ショ糖モノ才レ一卜、 ショ糖モノリノ レー卜、 ショ糖ジリノレー卜、 ショ糖卜リリノレ一卜等を挙げることができる。 本発明のべシクル分散物を構成するスフインゴシンおよび/またはその誘導 体 ( (B ) 成分;以下、 「スフインゴシン類」 という) としては、 スフインゴ シン骨格を持つ物質であればいずれでもよく、 例えばフィ卜スフインゴシン、 セラミド、 スフインゴミエリン、 セレブロシド等が挙げられ、 これらの 1種ま たは 2種以上を用いることができる。  Specific examples of preferred component (A) include, for example, sucrose monostearate, sucrose monoisostearate, sucrose diisostearate, sucrose monopalmitate, sucrose dipalmitate, sucrose monopalletate. Sucrose monolinoleate, sucrose dilinoleate, sucrose trilinoleate and the like. The sphingosine and / or its derivative (component (B); hereinafter, referred to as “sphingosines”) constituting the vesicle dispersion of the present invention may be any substance having a sufingosine skeleton. Examples thereof include sphingosine, ceramide, sphingomyelin, cerebroside and the like, and one or more of these can be used.
上記 (B ) 成分のうち、 セラミドは一般に高融点であるため、 通常は化粧料 への安定配合が困難であるが、 本発明によればそれが可能になるという点、 あ るいは、 皮膚の水分保持力を増大し、 化粧品製剤の保湿効果を高めるという点 において、 (B ) 成分として、 セラミドを用いることが特に好ましい。 化粧品に使用されているセラミドとしては、 酵母を利用して生成したセラミ ド、 化学合成によるセラミド、 植物から得られたセラミド等があり、 いずれも 好適に用いられる。 具体的には、 セラミド 1〜6が挙げられるが、 この中で、 セ ラミド 2、 セラミド 3またはセラミド 6が特に好ましい。 本発明のべシクル分散物を構成する水性成分 ( (C ) 成分) としては、 水ま たは水に可溶な成分であればいずれでもよく、 例えば、 水;エチルアルコール、 イソプロピルアルコール等のモノアルコール類;プロピレングリコール、 1, 3—ブチレングリコール、 ジプロピレングリコール、 ポリエチレングリコール 等のダリコール類;グリセリン、 ジグリセリン、 ポリグリセリン等のグリセ口 ール類;アロエベラ、 ハマメリス、 キユウリ、 レモン、 ラベンダー、 ローズ等 の植物抽出液等が挙げられ、 これらの 1種または 2種以上を用いることができ るが、 水あるいは水との混合物であることが好ましい。 また、 本発明のべシクル分散物には、 上記の必須構成成分の他、 任意の構成 成分として、 融点が 8 0 °C以下の脂肪酸および/または融点が 8 0 °C以下の高 級アルコール ( (D ) 成分) を配合することができる。 この (D ) 成分の配合 は、 スフインゴシン類の相溶性を上げ、 結晶析出を抑制し、 べシクルの安定性 を更に向上させることができる。 この (D) 成分としては、 融点が 8 0 °C以下 の脂肪酸や高級アルコールであれば、 飽和または不飽和であっても、 分岐また は直鎖であってもいずれでもよいが、 分岐があることが好ましく、 その 1種ま たは 2種以上を用いることができる。 具体的には、 イソステアリン酸等の脂肪 酸や、 イソセチルアルコール、 イソステアリルアルコール、 才クチルドデカノ —ル等の高級アルコールが挙げられる。 さらに、 本発明のべシクル分散物には、 その構成成分として、 ステロール類 ( ( E ) 成分) を配合することができる。 この (E ) 成分の配合により、 べシ クルの安定性や皮膚の保湿効果を格段に向上させることができる。 この (E ) 成分としてはステロール骨格を持つ物質あるいはその誘導体であればいずれで もよく、 例えばコレステロール、 フィトステロール、 マ力デミアンナッツ油脂 肪酸コレステリル、 ヤシ油脂肪酸コレステリル、 N—ラウロイルー L—グルタ ミン酸ジ (コレステリル ·ベへニル '才クチルドデシル) 等があげられ、 その 1種または 2種以上を用いることができるが、 中でもコレステロール、 フィ卜 ステロールが好ましい。 さらにまた、 本発明のべシクル分散物には、 その構成成分として、 美白剤、 抗炎症剤、 ビタミン類、 アミノ酸、 保湿剤および抗酸化剤よりなる群から選択 された薬効剤 ( (F) 成分) の少なくとも 1種を含有させることができる。 Of the above-mentioned component (B), ceramide generally has a high melting point, so that it is usually difficult to stably blend it into cosmetics. However, according to the present invention, this is possible, or It is particularly preferable to use ceramide as the component (B) from the viewpoint of increasing the water holding power and enhancing the moisturizing effect of the cosmetic preparation. Ceramides used in cosmetics include ceramides produced by using yeast, ceramides produced by chemical synthesis, and ceramides obtained from plants. All of them are suitably used. Specific examples include ceramides 1 to 6, among which ceramide 2, ceramide 3 and ceramide 6 are particularly preferred. The aqueous component (component (C)) constituting the vesicle dispersion of the present invention may be any water or water-soluble component. For example, water; monohydric compounds such as ethyl alcohol and isopropyl alcohol; Alcohols; Dalicols such as propylene glycol, 1,3-butylene glycol, dipropylene glycol, and polyethylene glycol; Glycerols such as glycerin, diglycerin, and polyglycerin; Aloe vera, Hamamelis, Cucumber, lemon, lavender, and rose And one or more of these can be used, but water or a mixture with water is preferred. In addition to the essential components described above, the vesicle dispersion of the present invention may further comprise, as optional components, fatty acids having a melting point of 80 ° C or less and / or higher alcohols having a melting point of 80 ° C or less. (D) component). The incorporation of the component (D) increases the compatibility of sphingocins, suppresses crystal precipitation, and can further improve the stability of the vesicle. As the component (D), any fatty acid or higher alcohol having a melting point of 80 ° C. or less may be saturated or unsaturated, branched or linear, but has a branch. It is preferable that one or two or more thereof can be used. Specific examples include fatty acids such as isostearic acid, and higher alcohols such as isocetyl alcohol, isostearyl alcohol, and octyldodecanol. Further, the vesicle dispersion of the present invention may contain sterols (component (E)) as its constituent components. By blending this component (E), the stability of the vesicle and the moisturizing effect on the skin can be remarkably improved. As the component (E), any substance having a sterol skeleton or a derivative thereof can be used. For example, cholesterol, phytosterol, coconut oil, cholesteryl fatty acid fatty acid, cholesteryl coconut fatty acid, N-lauroylu L-glutamate di (cholesteryl behenyl 's-octyldodecyl), etc., and one or more of them Two or more types can be used, and among them, cholesterol and phytosterol are preferable. Furthermore, the vesicle dispersion of the present invention has as its constituents a medicinal agent (F) selected from the group consisting of whitening agents, anti-inflammatory agents, vitamins, amino acids, humectants and antioxidants. ) Can be contained.
この (F) 成分は、 脂溶性あるいは水溶性の有効成分であり、 具体的には、 ァスコルビン酸およびその誘導体、 甘草抽出物等の美白剤;グリチルレチン酸 およびそれらの誘導体、 グリチルリチン酸およびその誘導体、 ァズレン等の抗 炎症剤; レチノール、 ビタミン A誘導体、 塩酸ピリドキシンおよびその誘導体、 ニコチン酸誘導体、 ビタミン Eおよびその誘導体等のビタミン類; ヒスチジン、 アルギニン、 セリン等のアミノ酸;コラーゲン、 ヒアルロン酸、 PCA等の保 湿剤;プチルヒドロキシトルエン等の抗酸化剤等が好ましい例として挙げられ、 これらの〗種または 2種以上を用いることができる。 本発明のべシクル分散物全体に対する各構成成分の好ましい含有量範囲につ いて示せば、 次の通りである。 構成成分 好ましい範囲  This component (F) is a fat-soluble or water-soluble active ingredient, and specifically includes whitening agents such as ascorbic acid and its derivatives, licorice extract; glycyrrhetinic acid and its derivatives, glycyrrhizic acid and its derivatives, Anti-inflammatory agents such as azulene; retinol, vitamin A derivatives, pyridoxine hydrochloride and its derivatives, nicotinic acid derivatives, vitamins such as vitamin E and its derivatives; amino acids such as histidine, arginine, serine; collagen, hyaluronic acid, PCA, etc. Preferred examples include a humectant; an antioxidant such as butylhydroxytoluene, and the like or two or more of these can be used. The preferred content ranges of the respective components with respect to the entire vesicle dispersion of the present invention are as follows. Component Preferred range
(A) 成分 0 1 20 % 2 ~1 0%  (A) Ingredient 0 1 20% 2 ~ 10%
(B) 成分 0 01 5 % 0. 1 ~ 2%  (B) Ingredient 0 01 5% 0.1 to 2%
(C) 成分 62 99 9% 83 〜97%  (C) Ingredient 62 99 9% 83-97%
(D) 成分 0 5 % 0. ·! 〜 2%  (D) Ingredient 0 5% 0. ~ 2%
(E) 成分 0 3 % 0. 01 ~ 1 %  (E) component 0 3% 0.01-1%
(F) 成分 0 5 % 0. 01 ~ 2 % 上記した (A) 成分および (B) 成分の総量は、 べシクル分散物全体に対し、 0. 1〜25%であることが好ましい。 (F) component 0 5% 0.01 to 2% The total amount of the components (A) and (B) is preferably 0.1 to 25% based on the whole vesicle dispersion.
また、 上記した (A) 成分と (B) 成分の構成比は特に限定されるものでは ないが、 保湿効果またはべシクル分散物の安定性の点において、 (B) 成分の 含有量が (A) 成分の含有量の、 質量比で、 0. 001倍〜 0. 4倍であるこ とが好ましい。 特に好ましくは、 0. 01倍〜0. 2倍である。  The composition ratio of the component (A) and the component (B) is not particularly limited, but the content of the component (B) is preferably (A) in view of the moisturizing effect or the stability of the vesicle dispersion. It is preferable that the content ratio of the component is 0.001 to 0.4 times by mass. Especially preferably, it is 0.01 times to 0.2 times.
更に (E) 成分の含有量も、 特に制約はないが、 (A) 成分の含有量の質量 比で 0. 001倍〜 0. 4倍であることが好ましく、 0. 1倍〜 0. 2倍であ ることが特に好ましい。 この範囲であれば、 べシクル分散物の安定性や皮膚の 保湿効果をさらに向上させることができる。 上記各成分を使用する本発明のべシクル分散物の製造方法としては、 種々の 方法を使用することができるが、 その一つの例としては、 次の方法が挙げられ る。 すなわち、 少なくとも、 (A) 成分および (B) 成分、 および必要に応じ て (D) 成分、 (E) 成分を、 (C) 成分に 40°C以上の温度で溶解または分 散させ、 ついでこの溶解ないし分散液 (溶解 ·分散液) を、 (C) 成分 (前記 (C) 成分と異なっていてもよい) に、 40°C以上の温度を保持しながら添加 し、 撹拌する工程を有する製造方法が好ましい。  Further, the content of the component (E) is not particularly limited, but is preferably 0.001 to 0.4 times, more preferably 0.1 to 0.2, by mass of the content of the component (A). It is particularly preferred that it be twice. Within this range, the stability of the vesicle dispersion and the moisturizing effect on the skin can be further improved. Various methods can be used as a method for producing the vesicle dispersion of the present invention using each of the above-mentioned components. One of the methods is as follows. That is, at least the components (A) and (B), and if necessary, the components (D) and (E) are dissolved or dispersed in the component (C) at a temperature of 40 ° C or higher. Adding a dissolving or dispersing liquid (dissolving / dispersing liquid) to the component (C) (which may be different from the component (C)) while maintaining the temperature at 40 ° C. or higher, and stirring the mixture. The method is preferred.
なお、 べシクル分散物の製造方法としては、 T c温度 (ゲル一液晶転移温 度) 以上で、 べシクルを構成する成分を十分水に膨潤させた後、 撹拌 昆合す る方法 (特許 31 261 93号公報) や、 有機溶媒を用いて、 リン脂質の薄膜 を形成させた後、 水または水溶液を添加して、 例えば超音波照射により微小な リボソームを得る方法等が従来から知られているが、 本発明のべシクル分散物 は、 有機溶媒を用いなくとも、 例えば、 (C) 成分としてジプロピレングリコ ール、 グリセリン等の多価アルコールを使用し、 これに各べシクル成分を溶解 後、 水を含有する (C) 成分 (前記 (C) 成分と異なっていてもよい) に添加 することにより、 容易にべシクル分散物を調製でき、 通常の撹拌機のみで、 直 径 0. 2 mm以下のべシクル分散物を容易に得ることが可能である。  The method for producing the vesicle dispersion includes a method in which components constituting the vesicle are sufficiently swollen in water at a temperature equal to or higher than the Tc temperature (gel-liquid crystal transition temperature), followed by stirring and stirring (Patent 31). No. 261 93) and a method of forming a thin film of a phospholipid using an organic solvent, and then adding water or an aqueous solution to obtain minute ribosomes by, for example, ultrasonic irradiation, is conventionally known. However, the vesicle dispersion of the present invention uses a polyhydric alcohol such as dipropylene glycol or glycerin as the component (C) without using an organic solvent, and dissolves each vesicle component in this. By adding it to the water-containing component (C) (which may be different from the above-mentioned component (C)), a vesicle dispersion can be easily prepared. Easy vesicle dispersion of less than mm It is possible to obtain.
上記溶解 ·分散液調製の際に用いられる (C) 成分としては、 上記した中で もジプロピレングリコールが特に好ましい。 また、 溶解 ·分散液を添加する側 の (C ) 成分としては、 水を 2 0 %以上含有するものが好ましいが、 特に水を 主成分とするものが好ましい。 更に、 上記溶解 ·分散液調製の際に、 同時に ( D ) 成分を用いることは、 (B ) 成分の融点を下げ、 (B ) 成分との相溶性 により結晶析出を抑制し、 べシクル分散物の安定性を向上させる点で特に好ま しい。 かくして得られた本発明のべシクル分散物は、 それを他の化粧料成分と組み 合わせて化粧料を得ることができる。 この化粧料の形態としては特に限定され ず、 溶液系、 可溶化系、 乳化系、 油性系、 水系、 あるいはそれらの系をあわせ 持つ、 二層型、 三層型等あらゆる剤型が可能である。 また本発明の化粧料はス キンケア化粧料、 頭髪化粧料、 メーキャップ化粧料等とすることができるが、 好ましくはスキンケア化粧料である。 中でも、 保湿効果の発現のために、 化粧 水、 乳液、 クリーム等の水性剤型であることが好ましい。 本発明のべシクル分 散物の化粧料全体に対する配合量は、 各剤型に合わせて選ぶことができるが、 0 . 1〜 1 0 0 %が好ましい。 The component (C) used in the above-mentioned dissolution / dispersion liquid preparation is as described above. Particularly, dipropylene glycol is particularly preferred. The component (C) on the side to which the dissolution / dispersion solution is added preferably contains water at 20% or more, and particularly preferably contains water as a main component. Furthermore, the use of the component (D) at the same time as the preparation of the above-mentioned dissolution / dispersion liquid lowers the melting point of the component (B), suppresses crystal precipitation due to compatibility with the component (B), and reduces the vesicle dispersion. It is particularly preferred in that it improves the stability of the device. The vesicle dispersion of the present invention thus obtained can be used in combination with other cosmetic ingredients to obtain a cosmetic. The form of the cosmetic is not particularly limited, and it can be in any form such as a solution type, a solubilizing type, an emulsifying type, an oil type, an aqueous type, or a combination of these types, such as a two-layer type or a three-layer type. . The cosmetic of the present invention may be a skin care cosmetic, a hair cosmetic, a makeup cosmetic, or the like, but is preferably a skin care cosmetic. Above all, in order to exhibit a moisturizing effect, it is preferable to use an aqueous dosage form such as a lotion, an emulsion or a cream. The blending amount of the vesicle dispersion of the present invention with respect to the whole cosmetic can be selected according to each dosage form, but is preferably 0.1 to 100%.
また、 本発明の化粧料には、 本発明のべシクル分散物の他に、 通常の化粧料 に使用される成分、 例えば、 水、 水可溶性成分、 保湿剤、 油剤、 界面活性剤、 増粘剤、 粉体、 色素、 紫外線吸収剤、 被膜形成性剤、 P H調整剤、 褪色防止剤、 酸化防止剤、 消泡剤、 美容成分、 防腐剤、 香料等をさらに適宜配合することが できる。  In addition, the cosmetic of the present invention includes, in addition to the vesicle dispersion of the present invention, components used in ordinary cosmetics, such as water, water-soluble components, humectants, oils, surfactants, and thickeners. Agents, powders, pigments, ultraviolet absorbers, film-forming agents, pH adjusters, anti-fading agents, antioxidants, defoamers, cosmetic ingredients, preservatives, fragrances, and the like can be further appropriately compounded.
水可溶性成分としては、 (C ) 成分で挙げたモノアルコール類 、 グリコール 類 、 グリセロール類 、 植物抽出液等の他、 ソルビ! ^一ル、 マルチトール、 シ ョ糖等の糖類、 塩化ナトリウム、 塩化マグネシウム、 乳酸ナトリウム等の電解 質類も用いることができる。  Examples of the water-soluble components include the monoalcohols, glycols, glycerols, plant extracts, etc. listed in the component (C), and sorbies, such as sugar, maltitol, and sucrose, sodium chloride, and chloride. Electrolytes such as magnesium and sodium lactate can also be used.
保湿剤としては、 タンパク質、 厶コ多糖、 コラーゲン、 エラスチン等があげ られる。  Examples of the humectant include protein, mucopolysaccharide, collagen, and elastin.
油剤としては、 動物油、 植物油、 合成油等の起源や、 固形油、 半固形油、 液 体油、 揮発性油等の性状を問わず、 炭化水素類、 油脂類、 ロウ類、 硬化油類、 エステル油類、 脂肪酸類、 高級アルコール類、 シリコーン油類、 フッ素系油類、 ラノリン誘導体類、 油性ゲル化剤類等が利用される。 Oils include hydrocarbons, oils and fats, waxes, hardened oils, regardless of their origin, such as animal oils, vegetable oils, and synthetic oils, and solid oils, semisolid oils, liquid oils, and volatile oils. Ester oils, fatty acids, higher alcohols, silicone oils, fluorinated oils, lanolin derivatives, oily gelling agents, etc. are used.
界面活性剤としては、 化粧品一般に用いられている界面活性剤であれぱいず れのものも使用できる。  As the surfactant, any surfactant generally used in cosmetics can be used.
増粘剤としては、 グァーガム、 コンドロイチン硫酸ナトリウム、 ヒアルロン 酸ナトリウム、 アラビアガム、 アルギン酸ナトリウム、 カラギ一ナン、 メチル セルロース、 ヒドロキシェチルセルロース、 カルボキシメチルセルロース、 力 ルポキシビ二ルポリマー、 ポリビニルアルコール、 ポリビニルピロリドン、 ポ リァクリル酸ナ卜リゥ厶等の水溶性高分子等が挙げられる。  Examples of thickeners include guar gum, sodium chondroitin sulfate, sodium hyaluronate, gum arabic, sodium alginate, carrageenan, methylcellulose, hydroxyethyl cellulose, carboxymethylcellulose, lipoxyvinyl polymer, polyvinyl alcohol, polyvinylpyrrolidone, and polyacrylyl. And water-soluble polymers such as acid sodium.
粉体としては、 板状、 紡錘状、 針状若しくは球状等の形状、 または、 粒子径、 多孔質若しくは無孔質等の粒子構造等により特に限定されず、 無機粉体類、 光 輝性粉体類、 積層フイルム末、 有機粉体類、 色素粉体類、 複合粉体類等が挙げ られる。 これら粉体は、 フッ素化合物、 シリコーン系油剤、 金属石ケン、 ロウ、 界面活性剤、 油脂、 炭化水素等を用いて公知の方法により表面処理を施したも のであっても良い。  The powder is not particularly limited by a plate-like, spindle-like, needle-like or spherical shape, or a particle diameter, a particle structure such as porous or non-porous, and the like. Body, laminated film powder, organic powder, pigment powder, composite powder and the like. These powders may be subjected to a surface treatment by a known method using a fluorine compound, a silicone oil agent, metal soap, a wax, a surfactant, a fat, a hydrocarbon, or the like.
紫外線吸収剤としては、 例えばべンゾフエノン系、 P A B A系、 ケィ皮酸系、 サリチル酸系、 4— t e r t—ブチルー 4 ' —メ卜キシジベンゾィルメタン、 才キシベンゾン等が挙げられ、 被膜形成剤としては (メタ) アクリル酸アルキ ル共重合体等のエマルシヨンポリマー形態のもの、 P H調整剤としては、 乳酸、 クェン酸等の α—ヒドロキシ酸およびその塩、 ェデ卜酸塩、 酸化防止剤として は、 例えば Q!—卜コフエロール、 プチルヒドロキシトルエン、 ァスコルビン酸 等、 美容成分としては、 例えばビタミン類、 消炎剤、 生薬等の薬効成分、 防腐 剤としては、 例えばパラ才キシ安息香酸エステル、 フエノキシエタノール等が あげられる 以上のようにして得られる本発明のべシクル分散物は、 平均粒径が 7 0〜2 O O At mであり、 同心円状に多層構造 (いわゆる玉ねぎ状構造) をした球状物 であるべシクルを水性媒体中に懸濁させたものであり、 肌の保湿効果に優れる セラミド等のスフインゴシン類を安定的にべシクル中に含有させることが可能 である。 Examples of the ultraviolet absorber include benzophenone-based, PABA-based, caesmic-acid-based, salicylic-acid-based, 4-tert-butyl-4'-methoxydibenzoylmethane, and xyxbenzone. Emulsion polymer form such as (meth) alkyl acrylate copolymer, etc., PH regulators include α-hydroxy acids such as lactic acid and citric acid and salts thereof, edetates, and antioxidants For example, Q! —Tocopherol, butylhydroxytoluene, ascorbic acid, etc., as beauty ingredients, for example, medicinal ingredients such as vitamins, anti-inflammatory agents, crude drugs, etc .; The vesicle dispersion of the present invention obtained as described above has an average particle size of 70 to 200 OO Atm, and is concentric. A vesicle, which is a sphere having a multilayered structure (so-called onion-like structure), is suspended in an aqueous medium, and has excellent skin moisturizing effect. Sphingosines such as ceramide are stably contained in the vesicle. Possible It is.
従って、 該べシクル分散物を化粧料中に配合することにより、 セラミド等の スフインゴシン類の有する優れた保湿効果等を得ることができるとともに、 そ の保存安定性等も向上させることができる。 実施例  Therefore, by blending the vesicle dispersion into a cosmetic, the excellent moisturizing effect of the sphingosines such as ceramide can be obtained, and the storage stability and the like thereof can be improved. Example
以下、 実施例および試験例をあげて本発明をさらに詳細に説明するが、 本発 明はこれら実施例により何ら制約されるものではない。 実施例 1  Hereinafter, the present invention will be described in more detail with reference to Examples and Test Examples, but the present invention is not limited by these Examples. Example 1
べシクル分散物 (1 ) :  Vesicle dispersion (1):
セラミド" 0.1 gとイソステアリン酸 O. l gを秤量し、 90°Cで加熱混合 した。 次いでこの混合物に、 0.5 gのショ糖脂肪酸エステル *2を分散したジブ ロピレングリコール 4 gを加え、 70°Cで均一に混合した。 これを 70°Cの精 製水 1 0gに添加し、 攪拌分散した後、 冷却することにより、 べシクル分散物 ( (B) 成分が (A) 成分の 0.2倍) を得た。 0.1 g of ceramide and 0.1 g of isostearic acid were weighed and mixed by heating at 90 ° C. Then, 4 g of dipropylene glycol in which 0.5 g of sucrose fatty acid ester * 2 was dispersed was added to the mixture, and 70 ° C was added. This was added to 10 g of purified water at 70 ° C, stirred and dispersed, and then cooled to obtain a vesicle dispersion (the component (B) was 0.2 times the component (A)). Obtained.
*1 セラミド 2  * 1 Ceramide 2
*2 DKエステル S— 1 60 (第一工業製薬社製) 実施例 2  * 2 DK Ester S—160 (Daiichi Kogyo Seiyaku Co., Ltd.) Example 2
べシクル分散物 (2) :  Vesicle dispersion (2):
セラミド" 0.01 gとイソステアリン酸 0.1 gを秤量し、 90°Cで加熱混 合した。 次いでこの混合物に、 0.5 gのショ糖脂肪酸エステル'2を分散したジ プロピレングリコール 4 gを加え、 70°Cで均一に混合した。 これを 70°Cの 精製水 1 0 gに添加し、 攪拌分散した後、 冷却することにより、 べシクル分散 物 ( (B) 成分が (A) 成分の 0.02倍) を得た。 Ceramide (0.01 g) and isostearic acid (0.1 g) were weighed and mixed by heating at 90 ° C. Then, to this mixture was added 0.5 g of sucrose fatty acid ester ' 2 dispersed in dipropylene glycol (4 g). This was added to 10 g of purified water at 70 ° C, stirred and dispersed, and then cooled to obtain a vesicle dispersion (the component (B) was 0.02 times the component (A)). Obtained.
*2 上記と同じ  * 2 Same as above
*3 セラミド 3 実施例 3 * 3 Ceramide 3 Example 3
べシクル分散物 (3) :  Vesicle dispersion (3):
セラミド" 0.2 gとイソステアリン酸 0.1 gを秤量し、 90°Cで加熱混合 した。 次いでこの混合物に、 0.5 gのショ糖脂肪酸エステル"を分散したジブ ロピレンダリコール 4 gを加え、 70°Cで均一に混合した。 これを 70°Cの精 製水 1 0 gに添加し、 攪拌分散した後、 冷却することにより、 べシクル分散物 ( (B) 成分が (A) 成分の 0.4倍) を得た。  Ceramide (0.2 g) and isostearic acid (0.1 g) were weighed and mixed by heating at 90 ° C. Then, to this mixture, 0.5 g of sucrose fatty acid ester was dispersed in 4 g of dipropylendalicol, and the mixture was added at 70 ° C. Mix evenly. This was added to 10 g of purified water at 70 ° C., stirred and dispersed, and then cooled to obtain a vesicle dispersion (the component (B) was 0.4 times the component (A)).
*1、 *2 上記と同じ。 実施例 4  * 1, * 2 Same as above. Example 4
べシクル分散物 (4) :  Vesicle dispersion (4):
セラミド" 0.005 g、 フィ卜ステロール 0.005 gおよびイソステアリ ン酸 0.1 gを秤量し、 9 (TCで加熱混合した。 次いでこの混合物に、 0.5 g のショ糖脂肪酸エステル"を分散したジプロピレングリコール 4 gを加え、 7 0°Cで均一に混合した。 これを 70°Cの精製水 1 0 gに添加し、 攪拌分散した 後、 冷却することにより、 べシクル分散物 ( (B) 成分が (A) 成分の 0.01 倍) を得た。  0.005 g of ceramide, 0.005 g of phytosterol and 0.1 g of isostearic acid were weighed and mixed by heating with 9 (TC. Then, 4 g of dipropylene glycol in which 0.5 g of sucrose fatty acid ester was dispersed was added to this mixture. In addition, the mixture was uniformly mixed at 70 ° C. This was added to 10 g of purified water at 70 ° C., stirred and dispersed, and then cooled, whereby the vesicle dispersion ((B) component (A) (0.01 times the component).
*1、 *2 上記と同じ。 比較例 1  * 1, * 2 Same as above. Comparative Example 1
べシクル分散物 (5)  Vesicle dispersion (5)
イソステアリン酸 0.1 gとショ糖脂肪酸エステル" 0.5gに、 ジプロピレ ングリコール 4 gを加えて 70°Cで均一に混合した。 これを精製水 5 gに添加 し、 攪拌分散することにより、 べシクル分散物を得た。  0.1 g of isostearic acid and 0.5 g of sucrose fatty acid ester were added to 4 g of dipropylene glycol and uniformly mixed at 70 ° C. This was added to 5 g of purified water, and dispersed by stirring to form a vesicle dispersion. I got something.
上記と同じ 試験例 1  Test example 1 same as above
べシクル分散物評価試験:  Vesicle dispersion evaluation test:
実施例 1から 4および比較例 1で得られたべシクル分散物について、 下記の 方法にょリ分散安定性と保湿効果の評価を行い判定した。 その結果を表 1 に示 す。 For the vesicle dispersions obtained in Examples 1 to 4 and Comparative Example 1, the following The method was evaluated by evaluating the dispersion stability and the moisturizing effect. The results are shown in Table 1.
<評価方法 >  <Evaluation method>
a .分散安定性  a.Dispersion stability
各試料を 4 0 °Cの恒温槽に 1 力月放置した後、 結晶物の析出および濁度の変 化を、 次に示す判定基準によリ目視で判断した。  After leaving each sample in a constant temperature bath at 40 ° C for one month, the precipitation of crystals and the change in turbidity were visually determined according to the following criteria.
( 判 定 )  (Judgment)
◎:全く認められない。  ◎: Not recognized at all.
〇:ほとんど認められない。  〇: Almost no recognition.
△:やや認められる。  Δ: Slightly recognized.
X:明らかに認められる。 (沈澱またはクリーミングが認められる) b .保湿効果  X: Clearly recognized. (Precipitation or creaming is observed) b. Moisturizing effect
1 0名の官能検査パネルに、 各試料を上腕に塗布してもらい、 6時間後の状 態を絶対評価基準を用いて 7段階に評価した。 各試料ごとの前記評価の評点の 平均値を求め、 4段階判定基準を用いて判定した。  Each sample was applied to the upper arm by 10 sensory test panels, and the condition after 6 hours was evaluated on a 7-point scale using absolute evaluation criteria. The average value of the above-mentioned evaluation scores for each sample was determined, and the evaluation was made using a four-step criterion.
( 1 ) 絶対評価基準  (1) Absolute evaluation criteria
(評 点 ) ( 評 価 )  (Score) (Evaluation)
6 非常に良い  6 very good
5 良い  5 Good
4 やや良い  4 Somewhat good
3  Three
2 やや悪い  2 Somewhat bad
1 悪い  1 Bad
0 非常に悪い  0 very bad
( 2 ) 4段階判定基準  (2) Four-step criteria
5点を超える 非常に良好  Very good over 5 points
3点を超えて 5点以下 良好 〇  More than 3 points and 5 points or less Good 〇
2点を超えて 3点以下 やや不良 △ 2点以下 不良 X 表 1 More than 2 points and 3 points or less Slightly poor △ 2 points or less Bad X Table 1
この結果、 べシクル分散物 (1 ) ~ (4) は、 分散安定性、 保湿性ともに良 好であった。 これから、 これらを配合する化粧料も分散安定性、 保湿性ともに 良好であると判断された。 実施例 5 As a result, the vesicle dispersions (1) to (4) were excellent in both dispersion stability and moisture retention. From this, it was judged that the cosmetics containing these also had good dispersion stability and good moisture retention. Example 5
べシクル化粧水:  Vesicle lotion:
表 2に示す組成および以下の製造方法によってべシクル化粧水 (本発明品 1 から 3) を調製した。 Vesicle lotions (products 1 to 3 of the present invention) were prepared by the composition shown in Table 2 and the following production method.
( 組成) (Composition)
表 2  Table 2
(%)  (%)
( 製造方法 ) ( Production method )
表 2の成分 1〜 6を混合溶解し、 これに成分 7〜1 0を混合溶解したものを 添加して攪拌し、 べシクル化粧水を得た。 比較例 2  Components 1 to 6 in Table 2 were mixed and dissolved, and a mixture obtained by mixing and dissolving components 7 to 10 was added thereto and stirred to obtain a vesicle lotion. Comparative Example 2
リボソーム化粧水:  Ribosome lotion:
(1 ) セラミド" 0. 1 g、 イソステアリン酸 0.05 gおよびコレステロール 0. 05 gを秤量し、 90°Cで加熱混合した。 この混合物に、 0. 5 gのリン月旨 質"を分散したジプロピレングリコール 4 gを加え、 7 0°Cで均一に混合した。 これを 7 0°Cの精製水 1 O gに添加し、 攪拌分散した後、 冷却することにより、 リポソ一厶液を得た。  (1) 0.1 g of ceramide, 0.05 g of isostearic acid, and 0.05 g of cholesterol were weighed and mixed by heating at 90 ° C. In this mixture, 0.5 g of phosphorus moon substance was dispersed. 4 g of propylene glycol was added and mixed uniformly at 70 ° C. This was added to 1 Og of purified water at 70 ° C., stirred and dispersed, and then cooled to obtain a liposome solution.
*1 上記と同じ。  * 1 Same as above.
*4 卵黄レシチン P L— 1 00 P (キューピ一社製) (2) 上記 (1 ) で得たリボソーム液 1 5%、 1, 3—プチレングリコール 6 %、 グリセリン 5%、 クェン酸 0. 1 %、 クェン酸ナトリウム 0.2%および精製水 を混合溶解し、 これに POE (30) ベへニルエーテル 0.5 %、 エタノール 8 %、 適量のパラオキシ安息香酸メチルおよび香料を混合溶解したものを添加し て撹拌し、 全量を 1 00%としてリボソーム化粧水を得た。 比較例 3 * 4 Egg yolk lecithin PL-100 P (Kupi) (2) Mix and dissolve 15% of the ribosome solution obtained in (1) above, 6% of 1,3-butylene glycol, 5% of glycerin, 0.1% of citrate, 0.2% of sodium citrate and purified water, A solution obtained by mixing and dissolving 0.5% of POE (30) behenyl ether, 8% of ethanol, an appropriate amount of methyl paraoxybenzoate and a flavor was added and stirred, and the total amount was adjusted to 100% to obtain a ribosome lotion. Comparative Example 3
乳化化粧水:  Emulsion lotion:
(1 ) セラミド" 0.1 gとイソステアリン酸 0.1 gを秤量し、 90°Cで加熱 混合した。 この混合物に、 0.5 gのポリ才キシエチレン (60 E.O.) 硬化ヒ マシ油を分散したジプロピレングリコール 4 gを加え、 70°Cで均一に混合し た。 これを 70°Cの精製水 〗 O gに添加し、 攪拌分散した後、 冷却することに より、 乳化物を得た。  (1) 0.1 g of “ceramide” and 0.1 g of isostearic acid were weighed and mixed by heating at 90 ° C. In this mixture, 4 g of dipropylene glycol in which 0.5 g of polyxylene (60 EO) hydrogenated castor oil was dispersed was added. Was added and mixed uniformly at 70 ° C. This was added to purified water / Og at 70 ° C., stirred and dispersed, and then cooled to obtain an emulsion.
*1 上記と同じ。  * 1 Same as above.
(2) 上記 (1 ) で得た乳化物 1 5%、 1, 3—プチレンダリコール 6 %、 ダリ セリン 5%、 クェン酸 0.1 %、 クェン酸ナトリウム 0.2%および精製水を混 合溶解し、 これに POE (30) ベへニルエーテル 0.5%、 エタノール 8%、 適量のパラ才キシ安息香酸メチルおよび香料を混合溶解したものを添加して撹 拌し、 全量を 1 00%として乳化化粧水を得た。 試験例 2 (2) 15% of the emulsion obtained in (1), 6% of 1,3-butylendalcol, 6% of dalyserin, 0.1% of citrate, 0.2% of sodium citrate and purified water are mixed and dissolved. To this, a mixture of 0.5% of POE (30) behenyl ether, 8% of ethanol, an appropriate amount of methyl para-hydroxybenzoate and a fragrance was added and stirred, and the mixture was stirred to make the total amount 100%, thereby obtaining an emulsified lotion. Was. Test example 2
実施例 5で得たべシクル化粧水 (本発明品 1から 3) 、 比較例 2のリポソ一 厶化粧水および比較例 3の乳化化粧水について、 その分散安定性、 保湿効果、 ベタつきのなさおよびにおいの変化について下記の方法により評価を行い判定 した。 その結果を表 3に示す。  The dispersion stability, moisturizing effect, non-stickiness and smell of the vesicle lotion obtained in Example 5 (Products 1 to 3 of the present invention), the liposome lotion of Comparative Example 2 and the emulsified lotion of Comparative Example 3 The change was evaluated by the following method. The results are shown in Table 3.
<評価方法 > a .分散安定性 <Evaluation method> a.Dispersion stability
前記、 試験例 1と同様に測定し、 同様の基準で判定した。 b .保湿効果および c .ベタつきのなさ  The measurement was performed in the same manner as in Test Example 1 described above, and the judgment was made based on the same criteria. b. moisturizing effect and c. non-stickiness
各化粧水について実際に顔に塗布した以外は、 前記、 試験例 1の保湿効果の 評価方法と同様に評価し、 同様の基準で判定した。 d .においの変化  Except that each lotion was actually applied to the face, it was evaluated in the same manner as in the method for evaluating the moisturizing effect of Test Example 1 described above, and judged according to the same criteria. d. Smell change
各化粧水を 4 0 °Cの恒温槽に 1力月放置した後、 室温に戻し、 ビン口でのに おいの変化を室温保管品と比較し、 次に示す判定基準により判断した。  Each lotion was left in a 40 ° C constant temperature bath for one month, then returned to room temperature, and the change in odor at the bottle mouth was compared with that of the room-temperature storage product, and judged according to the following criteria.
( 判 定 )  (Judgment)
◎ ほとんどない  ◎ almost none
〇 少しある。  あ る There is a little.
Δ ある。  Δ exists.
X かなりある。 表 3  X There are quite a few. Table 3
実施例 5のべシクル化粧水はすべて、 保湿効果と使用感に優れ、 分散安定性 も良好であり、 においの変化も許容範囲であった。 また、 実施例 5で用いたベ シクル分散物 (1 ) に代えて、 べシクル分散物 (2 ) 〜 (4 ) を用いたところ、 それらすベての化粧料について、 分散安定性、 保湿効果、 ベタつきのなさ、 に おいの変化のすべての点において良好なものが得られた。 All of the vesicle lotions of Example 5 were excellent in moisturizing effect and usability, good in dispersion stability, and the change in odor was within an acceptable range. When vesicle dispersions (2) to (4) were used instead of vesicle dispersion (1) used in Example 5, All of the cosmetics obtained were favorable in all respects of dispersion stability, moisturizing effect, non-stickiness, and change in odor.
一方、 比較例 2のリボソーム化粧水は、 ベタつきのなさ、 および経時におけ るにおいの変化において、 また比較例 3の乳化^:粧水は、 分散安定性、 保湿効 果において劣るものであった。 実施例 6  On the other hand, the ribosome lotion of Comparative Example 2 was inferior in stickiness and change in odor over time, and the emulsified ^: lotion of Comparative Example 3 was inferior in dispersion stability and moisturizing effect. . Example 6
クリーム:  Cream:
下記組成および製造方法によってクリームを調製し、 その分散安定性、 保湿 効果について評価を行った。  A cream was prepared according to the following composition and manufacturing method, and its dispersion stability and moisturizing effect were evaluated.
(成 分) ( % )  (Component) (%)
1. ステアリン酸 1 , 5  1. Stearic acid 1, 5
2. セ卜ステアリルアルコール 3.0  2. Cetostearyl alcohol 3.0
3. グリセリルモノステアレー卜 1.5  3. Glyceryl monostearate 1.5
4. スクヮラン 20.0  4. Squalane 20.0
5. ワセリン 5.0  5. Vaseline 5.0
6. グリセリン 7.0  6. Glycerin 7.0
7. 1 , 3—ブチレングリコール 5.0  7. 1, 3—butylene glycol 5.0
8. 実施例のべシクル分散物 *5 30.0 8. Example vesicle dispersion * 5 30.0
9. 乳酸ソーダ 1 - 0  9. Sodium lactate 1-0
1 0. キサンタンガ厶 0.05  1 0. Xanthan gum 0.05
1 1. 防腐剤 適 量  1 1. Appropriate amount of preservative
1 2. 水酸化カリウム 0.05  1 2. Potassium hydroxide 0.05
1 3. EDTA-2 N a 0.02  1 3. EDTA-2 Na 0.02
1 4. 精製水 残 量  1 4. Remaining amount of purified water
1 5. 香料 適 量  1 5. Appropriate amount of fragrance
*5 べシクル分散物 (1 ) 〜 (4) をそれぞれ用いた。  * 5 Vesicle dispersions (1) to (4) were used respectively.
(製造方法 )  (Production method )
A : 成分 1〜5、 1 5を 70°Cにて加熱混合した。 B : 成分 6〜 1 4を 70 °Cにて加熱混合した。 A: Components 1 to 5 and 15 were heated and mixed at 70 ° C. B: Components 6 to 14 were heated and mixed at 70 ° C.
C : Aに Bを添加して攪拌し、 これを冷却してクリームを得た。  C: B was added to A and stirred, and the mixture was cooled to obtain a cream.
実施例 6のクリームは、 べシクル分散物 (1 ) ~ (4) のいずれのものを用 いた場合でも、 保湿感に優れ、 安定性も良好であった。 実施例 7  The cream of Example 6 was excellent in moisturizing feeling and good in stability when any of the vesicle dispersions (1) to (4) was used. Example 7
乳 液 :  Latex :
下記組成および製造方法によって乳液を調製し、 その分散安定性、 保湿効果 について評価を行った。  An emulsion was prepared according to the following composition and production method, and its dispersion stability and moisturizing effect were evaluated.
(成 分) ( % )  (Component) (%)
1. スクヮラン 3. 0  1. Squalane 3.0
2. ジメチルポリシロキサン (20 c s) 1. 0  2. Dimethylpolysiloxane (20 cs) 1.0
3. ポリオキシエチレン (60) 硬化ヒマシ油 1 - 5  3. Polyoxyethylene (60) hydrogenated castor oil 1-5
4. セ卜ステアリルアルコール 0. 3  4. Setostearyl alcohol 0.3
5. 実施例のべシクル分散物 " 1 5. 0  5. Example vesicle dispersion "15.0
6. ジプロピレングリコール 7. 0  6. Dipropylene glycol 7.0
7. グリセリン 5. 0  7. Glycerin 5.0
8. アクリル酸—メタクリル酸アルキル共重合体 *10 0. 1 8. Acrylic acid-alkyl methacrylate copolymer * 10 0.1
9. 防腐剤 週 里  9. Preservatives
1 0. 水酸ィヒナ卜リウ厶 0. 03  1 0. Hydroxyl trihydrate 0. 03
1 1. E DT A- 2 N a 0. 02  1 1. EDT A- 2 N a 0.02
1 2. 香料 M 里  1 2. Spice M Sato
1 3. 精製水 残 里  1 3. Purified water residue
* 5 上記と同じ。  * 5 Same as above.
*10 ぺミュレン TR— 2 (NOVEON社製)  * 10 ぺ Mullen TR-2 (NOVEON)
(製造方法)  (Production method)
A 成分 1 ~ 7を 70°Cにて加熱混合した。  A components 1 to 7 were heated and mixed at 70 ° C.
B 成分 8〜 1 3を 70 °Cにて加熱混合した。  The B components 8 to 13 were heated and mixed at 70 ° C.
C Bに Aを添加して攪拌し、 これを冷却して乳液を得た ( 実施例 7の乳液は、 べシクル分散物 (1 ) 〜 (4) のいずれのものを用いた 場合でも、 保湿感に優れ、 安定性も良好であった。 実施例 8 A was added to CB and stirred, and this was cooled to obtain an emulsion ( When the emulsion of Example 7 used any of the vesicle dispersions (1) to (4), the emulsion had excellent moisturizing feeling and good stability. Example 8
スティック状アイクリ一厶:  Stick-shaped eye cream:
下記組成および製造方法によってスティック状アイクリームを調製し、 分散 安定性、 保湿効果について評価を行い判定した。  A stick-shaped eye cream was prepared according to the following composition and production method, and evaluated for dispersion stability and moisturizing effect.
( 成 分) ( % )  (Component) (%)
1. キャンデリラワックス 3· 0  1. Candelilla wax 3.0
2. ポリエチレンワックス 6.0  2. Polyethylene wax 6.0
3. マイクロクリスタリンワックス 2.5  3. Microcrystalline wax 2.5
4. セレシンワックス 6.0  4. Ceresin wax 6.0
5. パラフィン 1 0.0  5. Paraffin 1 0.0
6. トリイソオクタン酸グリセリル 1 0.0  6. Glyceryl triisooctanoate 1 0.0
7. 流動パラフィン 残 量  7. Liquid paraffin balance
8. 煙霧状シリカ 1 · 0  8. Fumed silica 1 · 0
9. グリセリン 3.0  9. Glycerin 3.0
1 0. 実施例のべシクル分散物 " 5.0  1 0. Example vesicle dispersion "5.0
*5 上記と同じ。  * 5 Same as above.
( 製造方法 )  ( Production method )
A : 1〜7を 1 00°Cにて均一溶解した。  A: 1 to 7 were uniformly dissolved at 100 ° C.
B : Aに 8〜1 0を加え、 均一に混合分散した。  B: 8 to 10 was added to A and mixed and dispersed uniformly.
C : Bをスティック容器に流し込み、 冷却固化してスティック状アイクリ ー厶を得た。  C: B was poured into a stick container, cooled and solidified to obtain a stick-shaped eye cream.
実施例 8のスティック状アイクリー厶は、 べシクル分散物 (1 ) 〜 (4) の いずれを用いた場合でも、 保湿感に優れ、 安定性も良好であった。 実施例 9  The stick-shaped eye cream of Example 8 was excellent in moisturizing sensation and good in stability when any of the vesicle dispersions (1) to (4) was used. Example 9
スティック状口紅: 下記組成および製造方法によってスティック状口紅を調製し、 評価を行った。 (成 分) ( % ) Sticky lipstick: A stick-like lipstick was prepared and evaluated according to the following composition and manufacturing method. (Component) (%)
1. エチレンプロピレンコポリマー 5.0  1. Ethylene propylene copolymer 5.0
2. ポリエチレンワックス 5.0  2. Polyethylene wax 5.0
3. キャンデリラワックス 7.0  3. Candelilla wax 7.0
4. 酢酸液状ラノリン 1 0.0  4. Liquid lanolin acetic acid 1 0.0
5. 卜リイソステアリン酸ジグリセリル 残 量  5. Diglyceryl triisostearate balance
6. ジイソステアリン酸ジグリセリル 3.0  6. Diglyceryl diisostearate 3.0
7. ポリブテン (分子量 700) 1 0.0  7. Polybutene (molecular weight 700) 1 0.0
8. 流動パラフィン 5.0  8. Liquid paraffin 5.0
9. 実施例のべシクル分散物 '6 0.5 9. Example vesicle dispersion ' 6 0.5
0. 実施例のべシクル分散物 " 0.3 0. Example vesicle dispersion "0.3
1. 赤色 202号 0.1 1. Red No. 202 0.1
2. 黄色 4号アルミニウムレーキ 1.5 2. Yellow No. 4 aluminum rake 1.5
3. 酸化チタン 2.0 3. Titanium oxide 2.0
4. 黒酸化鉄 0.2 4. Black iron oxide 0.2
5. 煙霧状シリカ 3.0 5. Fumed silica 3.0
6. ビタミン E 0.5 6. Vitamin E 0.5
7. 香料 適 量 7. Appropriate amount of fragrance
*6 べシクル分散物 (1 ) ~ (4) の精製水をそれぞれ 5 gにした他は、 べシクル分散物 (1 ) と同様の方法で調製したべシクル分散物。  * 6 Vesicle dispersion A vesicle dispersion prepared in the same manner as the vesicle dispersion (1), except that the purified water of each of (1) to (4) was changed to 5 g.
*7 次の方法で得たべシクル分散物。  * 7 Vesicle dispersion obtained by the following method.
セレブロシド 0. 1 gとセチルアルコール O. l gを秤量し、 70°C で加熱混合した。 次いでこの混合物に、 ショ糖イソステアリン酸エス テル (親水性) 0.4 g、 ショ糖リノール酸エステル (親油性) 0. 1 gおよびグリセリン 4 gを加え、 70°Cで均一に混合し、 これを 70 °Cの精製水 5 gに添加し、 攪拌分散した後、 冷却することにより得た c ( 製造方法)  0.1 g of cerebroside and 0.1 g of cetyl alcohol were weighed and mixed by heating at 70 ° C. Next, 0.4 g of sucrose isostearate ester (hydrophilic), 0.1 g of sucrose linoleate (lipophilic) and 4 g of glycerin were added to the mixture, and the mixture was uniformly mixed at 70 ° C. Add to 5 g of purified water at ° C, stir and disperse, and cool. C (Production method)
A : 成分〗〜 8を均一に加熱溶解した。 B : Aに成分 9〜1 6を均一に混合した。 A: Components 1 to 8 were uniformly heated and dissolved. B: Components 9 to 16 were uniformly mixed with A.
C : Bを型に溶融充填し、 冷却してスティック状口紅を得た。  C: B was melt-filled into a mold and cooled to obtain a stick-like lipstick.
実施例 9のスティック状口紅は、 いずれのものもべたつきのなさ、 保湿感と tゝつた点で優れたものであり、 特に肌あたりが滑らかなものであった。 実施例 1 0  Each of the stick-like lipsticks of Example 9 was excellent in terms of non-stickiness, moisturizing feeling and tactiness, and particularly had a smooth skin contact. Example 10
美容液 :  Essence:
下記組成および製造方法によって美容液を調製し、 分散安定性、 保湿効果に ついて評価を行い判定した。  A serum was prepared by the following composition and production method, and the dispersion stability and the moisturizing effect were evaluated and determined.
(成 分) ( % )  (Component) (%)
1. 実施例のべシクル分散物 40.0  1. Example vesicle dispersion 40.0
2. 実施例のべシクル分散物 *9 30.0 2. Example vesicle dispersion * 9 30.0
3. エチルアルコール 3.0  3. Ethyl alcohol 3.0
4. グリセリン 3.0  4. Glycerin 3.0
5. ヒア レロン酸ナトリウム 1 0.0  5. Sodium hyaluronate 1 0.0
6. 精製水 残 量  6. Remaining amount of purified water
7. 香料 M 量  7. M amount of fragrance
*8 べシクル分散物 1 ~4のセラミドに代えて、 スフインゴミエリンを用 い、 ジプロピレングリコールを半量にした以外は、 べシクル分散物 (1 ) 〜 (4) と同様の方法で調製したべシクル。  * 8 Vesicle dispersions Prepared in the same way as vesicle dispersions (1) to (4), except that sphingomyelin was used instead of ceramides 1 to 4 and dipropylene glycol was reduced to half the volume. Vesicles.
*9 次の方法で得たべシクル分散物。  * 9 Vesicle dispersion obtained by the following method.
セラミド" 0. 1 gとイソステアリン酸 0. 1 gを秤量し、 90°Cで加 熱混合した後、 ショ糖脂肪酸エステル" 0.4 gを分散したジプロピレ ングリコール 4 g、 ショ糖リノレン酸エステル 0.1 gおよびビタミ ン E 0.05 gを加え、 70°Cで均一に混合し、 この液を、 ヒスチジ ン 0.1 gを溶解した 70°Cの精製水 1 0 gに添加し、 攪拌分散した 後、 冷却することにより得た。  After weighing 0.1 g of ceramide "0.1 g" and 0.1 g of isostearic acid, heating and mixing at 90 ° C, 0.4 g of sucrose fatty acid ester was dispersed in 4 g of dipropylene glycol and 0.1 g of sucrose linolenate. Add 0.05 g of vitamin E and homogenously mix at 70 ° C, add this solution to 10 g of purified water at 70 ° C in which 0.1 g of histidine is dissolved, stir and disperse, then cool. Obtained by
*1、 上記と同じ。  * 1, Same as above.
( 製造方法) A:成分 1〜 7を均一に混合した。 ( Production method) A: Components 1 to 7 were uniformly mixed.
実施例 1 0の美容液は、 4種のべシクル分散物 ί8とべシクル分散物 "のいずれ のものを組み合わせて使用した場合でも、 保湿感に優れ、 安定性も良好であつ た。 産業上の利用可能性 The serum of Example 10 was excellent in moisturizing feeling and good in stability even when any of the four kinds of vesicle dispersion # 8 and vesicle dispersion was used in combination. Availability
本発明によると、 セラミド等のスフインゴシン類を安定的に含有させたべシ クル分散物を容易に得ることができる。 このべシクル分散物は、 化粧料等に配 合することができ、 これを配合した化粧料は、 分散安定性、 保湿効果、 ベたつ きのなさ、 変臭防止性等に優れている。  According to the present invention, a vesicle dispersion in which sphingosines such as ceramide are stably contained can be easily obtained. This vesicle dispersion can be incorporated into cosmetics and the like, and the cosmetics containing the vesicle dispersion are excellent in dispersion stability, moisturizing effect, non-stickiness, anti-odor and the like.

Claims

請求の範囲 The scope of the claims
1 - 少なくとも、 次の(A)成分、 (B) 成分および (C) 成分 1-at least the following components (A), (B) and (C)
(A) ショ糖脂肪酸エステル  (A) Sucrose fatty acid ester
(B) スフインゴシンおよび/またはその誘導体  (B) Sufingosine and / or a derivative thereof
(C) 水性成分  (C) aqueous component
を構成成分とすることを特徴とするべシクル分散物。 A vesicle dispersion comprising:
2. (A) 成分の一部または全てが親水性のショ糖脂肪酸エステルである請求 項 1に記載のべシクル分散物。 2. The vesicle dispersion according to claim 1, wherein part or all of the component (A) is a hydrophilic sucrose fatty acid ester.
3. (A) 成分の 50質量%以上がショ糖脂肪酸モノエステルである請求項 1 に記載のべシクル分散物。 3. The vesicle dispersion according to claim 1, wherein 50% by mass or more of the component (A) is a sucrose fatty acid monoester.
4. (A) 成分の一部がショ糖の不飽和脂肪酸エステルである請求項 1 に記載 のべシクル分散物。 4. The vesicle dispersion according to claim 1, wherein a part of the component (A) is an unsaturated fatty acid ester of sucrose.
5. (A) 成分の一部がショ糖の 7"—リノレン酸エステルである請求項 4に記 載のべシクル分散物。 5. The vesicle dispersion according to claim 4, wherein a part of the component (A) is a 7 "-linolenic acid ester of sucrose.
6. (B) 成分がセラミドである請求項 1に記載のべシクル分散物。 6. The vesicle dispersion according to claim 1, wherein the component (B) is ceramide.
7. (B) 成分がキラルセラミドである請求項 6に記載のべシクル分散物。 7. The vesicle dispersion according to claim 6, wherein the component (B) is chiral ceramide.
8. (B) 成分の含有量が (A) 成分の含有量の、 質量比で 0. 001倍〜 0. 4倍である請求項 1に記載のべシクル分散物。 8. The vesicle dispersion according to claim 1, wherein the content of the component (B) is 0.001 to 0.4 times by mass the content of the component (A).
9. さらに (D) 成分として、 融点が 80°C以下の脂肪酸および/または融点 が 80°C以下の高級アルコールを含有する請求項 1に記載のべシクル分散物。 9. The vesicle dispersion according to claim 1, further comprising, as component (D), a fatty acid having a melting point of 80 ° C or lower and / or a higher alcohol having a melting point of 80 ° C or lower.
1 0. さらに (E) 成分として、 (A) 成分の含有量に対し、 質量比で 0. 0 0 1倍〜 0. 4倍のステロール類を含有する請求項 1記載のべシクル分散物。 10. The vesicle dispersion according to claim 1, further comprising, as the component (E), a sterol in a weight ratio of 0.0001 to 0.4 times the content of the component (A).
1 1 · さらに (F) 成分として、 美白剤、 抗炎症剤、 ビタミン類、 アミノ酸、 保湿剤および抗酸化剤よりなる群から選択された薬効剤の少なくとも 1種を含 有することを特徴とする請求項 1記載のべシクル分散物。 Claims characterized in that the composition further comprises as component (F) at least one active ingredient selected from the group consisting of whitening agents, anti-inflammatory agents, vitamins, amino acids, humectants and antioxidants. Item 6. A vesicle dispersion according to item 1.
1 2. べシクル分散物全体に対して、 (A) 成分 0. 1〜20質量%、 (B) 成分 0. 0 1〜5質量%、 (C) 成分 62〜99. 9質量%、 (D) 成分 0〜 5質量%、 (E) 成分 0~3質量%および (F) 成分 0〜5質量%を含有する 請求項 1ないし請求項 1 1のいずれかの請求項に記載のべシクル分散物。 1 2. Component (A) 0.1 to 20% by mass, Component (B) 0.01 to 5% by mass, Component (C) 62 to 99.9% by mass, The vesicle according to any one of claims 1 to 11, comprising 0 to 5% by mass of component (D), 0 to 3% by mass of component (E), and 0 to 5% by mass of component (F). Dispersion.
1 3. べシクルが玉ねぎ状構造のものである請求項 1ないし請求項 1 1のいず れかの請求項に記載のべシクル分散物。 1 3. The vesicle dispersion according to any one of claims 1 to 11, wherein the vesicle has an onion-like structure.
1 4. べシクルの平均粒径が、 70~200 imである請求項 1 3記載のべシ クル分散物。 14. The vesicle dispersion according to claim 13, wherein the vesicle has an average particle size of 70 to 200 im.
1 5. 請求項 1ないし請求項 1 1のいずれかの請求項に記載のべシクル分散物 を含有することを特徴とする化粧料。 1 5. A cosmetic comprising the vesicle dispersion according to any one of claims 1 to 11.
1 6. 少なくとも (A) 成分および (B) 成分を 40°C以上の温度で、 多価ァ ルコールを含有する (C) 成分に溶解または分散させた後、 これを更に水を含 有する (C) 成分に、 40°C以上の温度を保持しながら添加し、 撹拌すること を特徴とする請求項 1ないし請求項 1 1のいずれかの請求項に記載のべシクル 分散物の製造方法。 1 6. At least component (A) and component (B) are dissolved or dispersed in component (C) containing polyhydric alcohol at a temperature of 40 ° C or more, and then further dissolved in water (C). The method for producing a vesicle dispersion according to any one of claims 1 to 11, wherein the component is added to the component while maintaining the temperature at 40 ° C or higher, followed by stirring.
PCT/JP2003/008517 2002-07-05 2003-07-04 Vesicle dispersion and cosmetic containing the same WO2004004676A1 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
KR1020057000160A KR101052493B1 (en) 2002-07-05 2003-07-04 Blessicle dispersions and cosmetics containing the same
JP2004519263A JP4527530B2 (en) 2002-07-05 2003-07-04 Vesicle dispersion and cosmetics containing the same
AU2003246269A AU2003246269A1 (en) 2002-07-05 2003-07-04 Vesicle dispersion and cosmetic containing the same
CA002491725A CA2491725A1 (en) 2002-07-05 2003-07-04 Vesicle dispersion and cosmetic containing the same
US10/518,549 US20050287095A1 (en) 2002-07-05 2003-07-04 Vesicle dispersion and cosmetic containing the same
HK06100016.4A HK1079982B (en) 2002-07-05 2006-01-03 Vesicle dispersion and cosmetic containing the same

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002-196852 2002-07-05
JP2002196852 2002-07-05

Publications (1)

Publication Number Publication Date
WO2004004676A1 true WO2004004676A1 (en) 2004-01-15

Family

ID=30112377

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2003/008517 WO2004004676A1 (en) 2002-07-05 2003-07-04 Vesicle dispersion and cosmetic containing the same

Country Status (9)

Country Link
US (1) US20050287095A1 (en)
JP (1) JP4527530B2 (en)
KR (1) KR101052493B1 (en)
CN (1) CN1332641C (en)
AU (1) AU2003246269A1 (en)
CA (1) CA2491725A1 (en)
HK (1) HK1079982B (en)
TW (1) TW200413020A (en)
WO (1) WO2004004676A1 (en)

Cited By (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006069933A (en) * 2004-08-31 2006-03-16 Kose Corp Oily solid cosmetic
JP2006199635A (en) * 2005-01-21 2006-08-03 Pola Chem Ind Inc Vesicle-based composition for external use
JP2007063145A (en) * 2005-08-29 2007-03-15 Kao Corp Oil-in-water type emulsified cosmetic
JP2008019230A (en) * 2006-06-16 2008-01-31 Pola Chem Ind Inc Ceramide-containing external preparation for skin
JP2008094810A (en) * 2006-10-16 2008-04-24 Kose Corp Ceramide-containing composition and external preparation for skin, containing the same
JP2008120731A (en) * 2006-11-13 2008-05-29 Kose Corp Vesicle composition and external preparation for skin, compounded with the composition
WO2009125816A1 (en) * 2008-04-09 2009-10-15 株式会社 資生堂 Vesicle and cosmetic containing the same
WO2010038816A1 (en) * 2008-09-30 2010-04-08 富士フイルム株式会社 Ceramide dispersion and method for producing same
WO2010058853A1 (en) * 2008-11-21 2010-05-27 富士フイルム株式会社 Ceramide dispersion, and process for producing same
KR20110079675A (en) * 2008-09-30 2011-07-07 후지필름 가부시키가이샤 Ceramide dispersion and method for producing same
WO2012133817A1 (en) * 2011-03-31 2012-10-04 花王株式会社 Vesicle composition
JP2013124226A (en) * 2011-12-14 2013-06-24 Pola Chemical Industries Inc Emulsified composition containing ceramide
WO2013122102A1 (en) * 2012-02-13 2013-08-22 花王株式会社 Method for producing vesicle composition
JP2014019665A (en) * 2012-07-18 2014-02-03 Kao Corp Production method of vesicle composition
JPWO2013146387A1 (en) * 2012-03-28 2015-12-10 味の素株式会社 Emulsifying dispersant and emulsifying composition
JP2016044167A (en) * 2014-08-26 2016-04-04 小林製薬株式会社 External composition
JP2017039681A (en) * 2015-08-22 2017-02-23 クローダジャパン株式会社 Skin topical agent composition, and skin topical agent containing that skin topical agent composition
JP2021511334A (en) * 2018-01-19 2021-05-06 エルジー ハウスホールド アンド ヘルスケア リミテッド Cosmetic composition containing particles containing a high content of ceramide and a method for producing the same.
CN114699337A (en) * 2022-03-29 2022-07-05 成都丁因生物科技有限公司 Multilayer free radical targeting vesicle for delaying skin aging

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0714256A2 (en) * 2006-08-09 2013-06-18 Takasago Internat Corp U S A topical composition, topical formulation, method for preparing a topical composition, method for treating a skin condition, method for treating a skin irritation, and method for strengthening, firming, rejuvenating or restoring skin condition
JP5339813B2 (en) * 2007-08-09 2013-11-13 花王株式会社 Reverse vesicle composition
JPWO2009145299A1 (en) * 2008-05-29 2011-10-13 富士フイルム株式会社 Ceramide dispersion
FR2949968B1 (en) * 2009-09-17 2013-08-02 Oreal INJECTABLE COMPOSITION COMPRISING A VESICULAR DISPERSION COMPRISING CERAMIDES AND HYALURONIC ACID, USE AND METHOD
JP5676319B2 (en) 2010-04-07 2015-02-25 富士フイルム株式会社 Method for producing aqueous cosmetics
JP6016728B2 (en) * 2013-08-02 2016-10-26 富士フイルム株式会社 Ceramide dispersion composition
EP3536399A4 (en) * 2016-12-27 2020-07-22 Kao Corporation Method for producing ceramide microparticle dispersion
KR101937699B1 (en) * 2018-05-04 2019-01-11 코스맥스 주식회사 Vesicle for enhancing the skin penetration, and preparation method of the same
KR102325570B1 (en) * 2021-07-28 2021-11-12 주식회사 라오가닉 Cosmetic composition for moisturizing and skin barrier improvement containing nanoliposomes containing oxygen water and ceramide, and method for preparing the same

Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61271205A (en) * 1985-05-24 1986-12-01 Kanebo Ltd Skin cosmetic
FR2730931A1 (en) * 1995-02-24 1996-08-30 Oreal Aq. vesicular dispersion with lipid phase membrane
JPH0967389A (en) * 1995-08-30 1997-03-11 Snow Brand Milk Prod Co Ltd Production of lipid containing saccharide
JPH11199462A (en) * 1998-01-12 1999-07-27 Nippon Fine Chem Co Ltd Sphingolipid-surfactant complex
JP2002145758A (en) * 2000-09-04 2002-05-22 Kose Corp Cosmetic

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61207324A (en) * 1985-03-11 1986-09-13 Agency Of Ind Science & Technol Liposome
JPS63192703A (en) * 1987-02-04 1988-08-10 Kao Corp External agent for skin
JP3008212B2 (en) * 1990-11-26 2000-02-14 花王株式会社 Transparent or translucent cosmetics
JP3299054B2 (en) * 1994-10-19 2002-07-08 花王株式会社 Skin cosmetics
CN1211073C (en) * 1998-01-16 2005-07-20 华东师范大学 Process for preparing ceramide liposome emulsion
US20040033246A1 (en) * 2002-06-25 2004-02-19 Kose Corporation Cosmetic for prevention of skin aging and agent for prevention of skin aging

Patent Citations (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61271205A (en) * 1985-05-24 1986-12-01 Kanebo Ltd Skin cosmetic
FR2730931A1 (en) * 1995-02-24 1996-08-30 Oreal Aq. vesicular dispersion with lipid phase membrane
JPH0967389A (en) * 1995-08-30 1997-03-11 Snow Brand Milk Prod Co Ltd Production of lipid containing saccharide
JPH11199462A (en) * 1998-01-12 1999-07-27 Nippon Fine Chem Co Ltd Sphingolipid-surfactant complex
JP2002145758A (en) * 2000-09-04 2002-05-22 Kose Corp Cosmetic

Cited By (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2006069933A (en) * 2004-08-31 2006-03-16 Kose Corp Oily solid cosmetic
JP4571514B2 (en) * 2005-01-21 2010-10-27 ポーラ化成工業株式会社 Vesicle external composition
JP2006199635A (en) * 2005-01-21 2006-08-03 Pola Chem Ind Inc Vesicle-based composition for external use
JP2007063145A (en) * 2005-08-29 2007-03-15 Kao Corp Oil-in-water type emulsified cosmetic
JP2008019230A (en) * 2006-06-16 2008-01-31 Pola Chem Ind Inc Ceramide-containing external preparation for skin
JP2008094810A (en) * 2006-10-16 2008-04-24 Kose Corp Ceramide-containing composition and external preparation for skin, containing the same
JP2008120731A (en) * 2006-11-13 2008-05-29 Kose Corp Vesicle composition and external preparation for skin, compounded with the composition
WO2009125816A1 (en) * 2008-04-09 2009-10-15 株式会社 資生堂 Vesicle and cosmetic containing the same
WO2010038816A1 (en) * 2008-09-30 2010-04-08 富士フイルム株式会社 Ceramide dispersion and method for producing same
KR20110079675A (en) * 2008-09-30 2011-07-07 후지필름 가부시키가이샤 Ceramide dispersion and method for producing same
KR101646948B1 (en) 2008-09-30 2016-08-09 후지필름 가부시키가이샤 Ceramide dispersion and method for producing same
WO2010058853A1 (en) * 2008-11-21 2010-05-27 富士フイルム株式会社 Ceramide dispersion, and process for producing same
JP5490017B2 (en) * 2008-11-21 2014-05-14 富士フイルム株式会社 Ceramide dispersion and method for producing the same
JP2016084360A (en) * 2011-03-31 2016-05-19 花王株式会社 Vesicle composition
US9694076B2 (en) 2011-03-31 2017-07-04 Kao Corporation Vesicle composition
EP2692334A1 (en) * 2011-03-31 2014-02-05 Kao Corporation Vesicle composition
EP2692334A4 (en) * 2011-03-31 2014-11-19 Kao Corp Vesicle composition
JP2012214470A (en) * 2011-03-31 2012-11-08 Kao Corp Vesicle composition
WO2012133817A1 (en) * 2011-03-31 2012-10-04 花王株式会社 Vesicle composition
JP2013124226A (en) * 2011-12-14 2013-06-24 Pola Chemical Industries Inc Emulsified composition containing ceramide
WO2013122102A1 (en) * 2012-02-13 2013-08-22 花王株式会社 Method for producing vesicle composition
JPWO2013146387A1 (en) * 2012-03-28 2015-12-10 味の素株式会社 Emulsifying dispersant and emulsifying composition
JP2014019665A (en) * 2012-07-18 2014-02-03 Kao Corp Production method of vesicle composition
JP2016044167A (en) * 2014-08-26 2016-04-04 小林製薬株式会社 External composition
JP2017039681A (en) * 2015-08-22 2017-02-23 クローダジャパン株式会社 Skin topical agent composition, and skin topical agent containing that skin topical agent composition
JP2021511334A (en) * 2018-01-19 2021-05-06 エルジー ハウスホールド アンド ヘルスケア リミテッド Cosmetic composition containing particles containing a high content of ceramide and a method for producing the same.
JP7412838B2 (en) 2018-01-19 2024-01-15 エルジー ハウスホールド アンド ヘルスケア リミテッド Cosmetic composition containing particles containing high ceramide content and method for producing the same
CN114699337A (en) * 2022-03-29 2022-07-05 成都丁因生物科技有限公司 Multilayer free radical targeting vesicle for delaying skin aging

Also Published As

Publication number Publication date
HK1079982B (en) 2008-03-28
JPWO2004004676A1 (en) 2005-11-04
CN1332641C (en) 2007-08-22
CN1665478A (en) 2005-09-07
JP4527530B2 (en) 2010-08-18
KR20050018953A (en) 2005-02-28
US20050287095A1 (en) 2005-12-29
TWI329023B (en) 2010-08-21
HK1079982A1 (en) 2006-04-21
KR101052493B1 (en) 2011-07-28
CA2491725A1 (en) 2004-01-15
AU2003246269A1 (en) 2004-01-23
TW200413020A (en) 2004-08-01

Similar Documents

Publication Publication Date Title
WO2004004676A1 (en) Vesicle dispersion and cosmetic containing the same
JP5508682B2 (en) Oil-in-water emulsion composition and method for producing the same
TWI396560B (en) Skin external preparation in the form of water-in-oil emulsion comprising ceramide
JP6377381B2 (en) Liposome composition
KR101642054B1 (en) Composition for transdermal transfer and cosmetics containing the same
KR20130055069A (en) O/w emulsion having recrystallized particle and cosmetic composition comprising thereof
JP2010184908A (en) Emulsified composition and cosmetic comprising the same, and skin care preparation for external use
KR102080459B1 (en) Cosmetic composition having multiple emulsion formulation for stabilizing active ingredient and enhancing the skin penetration
JP5662774B2 (en) Emulsified composition
JP2005179313A (en) Method for producing base agent for skin cosmetic, and skin cosmetic
JP5183919B2 (en) Oil-in-water fine emulsion composition and method for producing the same
WO2015147137A1 (en) Ceramide-formulated external agent composition
JP2001233754A (en) Emulsion type skin care preparation
JPS61204109A (en) Emulsion-type composition for external use
JP5642002B2 (en) Vesicle-containing composition, cosmetic or external preparation containing the same
TW200916118A (en) External preparation for skin
JP3441387B2 (en) Moisturizer, skin cosmetics and bath additives
JP4592347B2 (en) External preparation composition
JP2002302414A (en) Sphingolipid structural matter-containing emulsified composition and method for producing the same
JP4067211B2 (en) Skin preparation
JPH09132512A (en) Lamellar structure of sterol fatty acid ester
JP5329489B2 (en) External preparation composition
KR100501309B1 (en) Manufacturing Method of Nano-emulsified Cosmetic Composition Containing Arbutin
JP2002145758A (en) Cosmetic
KR20230150260A (en) liposome composition

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG US UZ VC VN YU ZA ZM ZW

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
WWE Wipo information: entry into national phase

Ref document number: 2004519263

Country of ref document: JP

WWE Wipo information: entry into national phase

Ref document number: 10518549

Country of ref document: US

WWE Wipo information: entry into national phase

Ref document number: 2491725

Country of ref document: CA

Ref document number: 1020057000160

Country of ref document: KR

Ref document number: 20038157470

Country of ref document: CN

WWP Wipo information: published in national office

Ref document number: 1020057000160

Country of ref document: KR

122 Ep: pct application non-entry in european phase